The Journal of Infectious Diseases Volume 173 • Number 1 January 1996

Effect of Antibody Alone and Combined with Acyclovir 52 Protection of MN-rgpI20-Immunized Chimpanzees from on Neonatal Herpes Simplex Virus Infection in Heterologous Infection with a Primary Isolate of Human Guinea Pigs Immunodeficiency Virus Type I Fernando 1. Bravo, Nigel Bourne, Phillip W. Berman, Krishna K. Murthy, Terri Wrin, Christopher J. Harrison, Chitra Mani, Joann C. Vennari, E. Kathy Cobb, Donna 1. Eastman, Lawrence R. Stanberry, Martin G. Myers, Mark Champe, Gerald R. Nakamura, Donna Davison, and David I. Bernstein Michael F. Powell, Jeanine Bussiere, Donald P. Francis, Tom Matthews, 7 Herpes Simplex Virus Protein Targets for CD4 and CD8 Timothy 1. Gregory, and John F. Obijeski Lymphocyte Cytotoxicity in Cultured Epidermal Keratinocytes Treated with Interferon-y 60 Neutralizing and Infection-Enhancing Antibody Responses

Zorka Mikloska, Alison M. Kesson, Mark E. T. Penfold, to Human Immunodeficiency Virus Type I in Long-Term Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 and Anthony L. Cunningham Nonprogressors David C. Montefiori, Giuseppe Pantaleo, Lisa M. Fink, 18 Liposome-Encapsulated (S)-I-(3-Hydroxy-2­ Jin Tao Zhou, Ji Ying Zhou, Miroslawa Bilska, Phosphonylmethoxypropyl)cytosine for Long-Acting G. Diego Miralles, and Anthony S. Fauci Therapy of Viral Retinitis Baruch D. Kuppermann, Kerry K. Assil, Chou Vuong, 68 Laboratory Diagnosis of Infection Status in Infants Gilberto Besen, Clayton A. Wiley, Erik De Clercq, Perinatally Exposed to Human Immunodeficiency Virus Germaine Bergeron-Lynn, James D. Connor, Type I Michael Pursley, David Munguia. Morris 0. Paul, Surya Tetali, Martin L. Lesser, and William R. Freeman Elaine 1. Abrams, Xue Ping Wang, Regina Kowalski, Mahrukh Bamji, Barbara Napolitano, Leslie Gulick, 24 Use of Intrinsic and Extrinsic Helper Epitopes for In Vivo Saroj Bakshi, and Savita Pahwa Induction of Anti-Hepatitis C Virus Cytotoxic T Lymphocytes (CTL) with CTL Epitope Peptide 77 Factors Associated with Cytomegalovirus Infection among Mutsunori Shirai, Ming Chen, Tatsumi Arichi, Human Immunodeficiency Virus Type I-Seronegative Tsutomu Masaki, Mikio Nishioka. Mark Newman, and -Seropositive Women from an Urban Minority Teruko Nakazawa, Stephen M. Feinstone, Community and Jay A. Berzofsky Lorraine M. Clarke, Ann Duerr, Joseph Feldman, Marcelino F. Sierra, Bennett 1. Daidone, 32 Molecular Epidemiology of Virus: Identification and Sheldon H. Landesman of Pathways of and Implications for Measles Elimination 83 Effect of Human Immunodeficiency Virus Type I Jennifer S. Rota. Janet L. Heath, Paul A. Rota, Infection on the Antibody Response to a Glycoprotein Gail E. King, Maria L. Celma, Juan Carabaiia, Conjugate Pneumococcal : Results from a Rafael Fernandez-Munoz, David Brown, Randomized Trial Li lin. and William J. Bellini Faruque Ahmed, Mark C. Steinhoff, Maria C. Rodriguez-Barradas, 38 Elevated Plasma Levels of Tumor Necrosis Factor Robert G. Hamilton. Daniel M. Musher, (TNF)-a, Soluble TNF Receptors, Interleukin (IL)-6, and Kenrad E. Nelson and IL-I 0 in Patients with Hemorrhagic Fever with Renal Syndrome 91 Pyrimethamine for Primary Prophylaxis of Toxoplasmic Mats Linderholm, Clas Ahlm, Bo Settergren, Encephalitis in Patients with Human Immunodeficiency Anders Waage, and Arne Tdrnvik Virus Infection: A Double-Blind, Randomized Trial Catherine Leport, Genevieve Chene, Philippe Morlat, 44 Effective Immunization with Live Attenuated Influenza A Benjamin 1. Luft, Franck Rousseau, Sophie Pueyo, Virus Can Be Achieved in Early Infancy Richard Hafner. Jose Miro, Jean Aubertin, Mary Lou Clements. Mamodikoe K. Makhene, Roger Salamon. Jean-Louis Vilde, Ruth A. Karron, Brian R. Murphy. Mark C. Steinhoff, and ANRS 005-ACTG 154 Group Members Kanta Subbarao, Modena H. Wilson, Pediatric Care Center, and Peter F. Wright 98 Effect of Tampon Composition on Production of Toxic 172 The Influence of Capsulation and Lipooligosaccharide Shock Syndrome Toxin-l by Staphylococcus aureus Structure on Neutrophil Adhesion Molecule Expression In Vitro and Endothelial Injury by Neisseria meningitidis Jeffrey Parsonnet, Paul A. Modern, Nigel J. Klein, CatherineA. Ison, Mark Peakman, and Kristine D. Giacobbe Michael Levin, Sven Hammerschmidt, Matthias Frosch, and Robert S. Heyderman 104 Role of Staphylokinase in the Acquisition of Plasmin(ogen)-Dependent Enzymatic Activity by 180 A Virulent Nonencapsulated Haemophilus injiuenzae Staphylococci VictorNizet, Kenneth F. Colina, Jon R. Almquist, Robert B. Christner and Michael D. P. Boyle Craig E. Rubens, and Arnold L. Smith 113 A Modified Farr Assay Is More Specific than ELISA for 187 Suppression of Acute Ixodes scapularis-Induced Borrelia Measuring Antibodies to Streptococcus pneumoniae burgdorferi Infection using Tumor Necrosis Factor-a, Capsular Polysaccharides Interleukin-2, and Interferon-y Moon H. Nahm, GeorgeR. Siber, and Jitka V. Olander Nordin Zeidner, Matthew Dreitz, Debra Belasco, and Durland Fish 119 Immunogenicity and Efficacy of Streptococcus pneumoniae Polysaccharide-Protein Conjugate Vaccines 196 Characterization of the Catalase-Peroxidase Gene (katG)

against Homologous and Heterologous Serotypes in the and inhA Locus in Isoniazid-Resistant and -Susceptible Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Chinchilla Otitis Media Model Strains of Mycobacterium tuberculosis by Automated G. Scott Giebink, Jeanine D. Meier, Moses K. Quartey, DNA Sequencing: Restricted Array of Mutations Carol L. Liebeler, and Chap T. Le Associated with Drug Resistance James M. Musser, Vivek Kapur, Diana L. Williams, 128 Subtyping of Common Pediatric Pneumococcal Serotypes Barry N. Kreiswirth, Dick van Soolingen, from Invasive Disease and Pharyngeal Carriage in Finland and Jan D. A. van Embden Aino K. Takala, Jaana Vuopio-Varkila, Eveliina Tarkka, Maija Leinonen, 203 Treatment of Experimental Gram-Negative and and James M. Musser Gram-Positive Bacterial Sepsis with the Hematoregulatory Peptide SK&F 107647 136 Antibody-Secreting Cells and their Relation to Humoral Peter L. DeMarsh, Grace I. Wells, Antibodies in Serum and in Nasopharyngeal Aspirates in ThomasF. Lewandowski, Carrie L. Frey, Children with Pneumococcal Acute Otitis Media Pradip K. Bhatnagar, and Evelyn Judith R. Ostovic Tea Nieminen, Anni Virolainen, Helena Kdyhty, Jussi Jero, Pekka Karma, Maija Leinonen, 212 Intracellular Pathways Involved in Tumor Necrosis and Juhani Eskola Factor-a Release by Human Monocytes on Stimulation with Lipopolysaccharide or Staphylococcal Peptidoglycan 142 Quantitative Determination of Antibodies to Type III Are Partly Similar Group B Streptococcal Polysaccharide Eva Mattsson, H. Van Dijk, K. Van Kessel, J. Verhoef, Hilde-Kari Guttormsen, Carol J. Baker, A. Fleer, and J. Rollof Morven S. Edwards, Lawrence C. Paoletti, and Dennis L. Kasper 219 Risk Factors for Fluconazole-Resistant Candidiasis in Human Immunodeficiency Virus-Infected Patients 151 Molecular Genetics of Resistance to Both Ceftazidime Janine R. Maenza, Jeanne C. Keruly, and I3-Lactam-I3-Lactamase Inhibitor Combinations in Richard D. Moore, Richard E. Chaisson, Klebsiellapneumoniae and In Vivo Response to I3-Lactam William G. Merz, and Joel E. Gallant Therapy Louis B. Rice, Lenore L. Carias, Robert A. Bonomo, 226 Surface Localization, Regulation, and Biologic Properties and David M. Shlaes of the 96-kDa Alcohol!Aldehyde Dehydrogenase (EhADH2) of Pathogenic Entamoeba histolytica 159 Neutralization of Macrophage Inflammatory Protein-2 Becky M. Flores, Samuel L. Stanley, Jr., Attenuates Neutrophil Recruitment and Bacterial Tai-Soon Yong, Manzoor Ali, Wengang Yang, Clearance in Murine Klebsiella Dana L. Diedrich, and Bruce E. Torian Marc J. Greenberger, Robert M. Strieter, Steven L. Kunkel, Jean M. Danforth, 232 Cryptosporidium parvum: Intensity of Infection and Lauri L. Laichalk, Daniel C. McGillicuddy, Oocyst Excretion Patterns in Healthy Volunteers and Theodore J. Standiford Cynthia L. Chappell, Pablo C. Okhuysen, Charles R. Sterling, and Herbert L. DuPont 166 Neuroprotective Effect of Excitatory Amino Acid Antagonist Kynurenic Acid in Experimental Bacterial Concise Communications Stephen L. Leib, Young S. Kim, Donna M. Ferriero, and Martin G. Tauber 237 Hantavirus Serologies in Patients Hospitalized with Community-Acquired Pneumonia Paul G. Auwaerter, David Oldach, Linda M. Mundy, Albert Burton, Mary Laird Warner, Estil Vance, Richard D. Moore. and Cvnthia A. Rossi 240 Tissue Macrophages Are Infected by Human 263 Mycobacterium avium Complex Sputum Isolates from Cytomegalovirus In Vivo Patients with Respiratory Symptoms in Guinea-Bissau Christian Sinzger, Bodo Plachter, Annemarie Grefte, Tuija Koivula, Sven Hoffner, Niclas Winqvist, T Houw The, and Gerhard Jahn Anders Naucler, Francisco Dias, Lidia Lacerda, Stefan Svenson, Renee Norberg, 245 A Community-Based Study of Human Immunodeficiency and Gunilla Kiillenius Virus Type 2 Provirus Load in a Rural Village in 265 Evidence for Genetic Regulation of Susceptibility to West Africa Toxoplasmic Encephalitis in AIDS Patients K. Ariyoshi, N. Berry, A. Wilkins, D. Ricard, P. Aaby, Yasuhiro Suzuki, Sin-Yew Wong, F. Carl Grumet, A. Naucler, P. T. Ngom, 0. Jobe, S. Jaffar, F. Dias, Jeffrey Fessel, Jose G. Montoya, Andrew R. Zolopa, R. S. Tedder, and H. Whittle Amy Portmore, Francoise Schumacher-Perdreau, Matthias Schrappe, Stefan Koppen, Bernhard Ruf, 248 Frequent Presence of a Novel Herpesvirus Genome in Byron William Brown, and Jack S. Remington Lesions of Human Immunodeficiency Virus-Negative Kaposi's Sarcoma 269 Impairment of Tetanus Toxoid-Specific Thl-like Immune Steven Chuck, Robert M. Grant, Responses in Humans Infected with Schistosoma mansoni Edward Katongole-Mbidde, Marcus Conant, Elizabeth A. Sabin, Maria Ilma Araujo, and Don Ganem Edgar M. Carvalho, and Edward 1. Pearce Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021

252 Bactericidal/Permeability-Increasing Protein, a Correspondence Lipopolysaccharide-Specific Protein on the Surface of Human Peripheral Blood Monocytes 273 Population Pharmacokinetics of Didanosine in Patients Mieke A. Dentener, Gaby 1. M. Francot, with Human Immunodeficiency Virus Infection and Wim A. Buurman George E. Harb, Jaap W. Mandema, Tom Delahunty, Neal B. Benowitz, Rebecca Coleman, Lewis B. Sheiner, 256 Pneumococcal Conjugate Vaccine Primes for Antibody and Mark A. Jacobson Responses to Polysaccharide Pneumococcal Vaccine after Treatment of Hodgkin's Disease 274 V(3 Expression in Healthy Subjects and during Streptococcal Infection Christina Y. Chan, Deborah C. Molrine, C. A. Michie Suzanne George, Nancy 1. Tarbell, Peter Mauch, Lisa Diller, Robert C. Shamberger, 274 Reply Nichole R. Phillips, Amy Goorin, Malak Kotb and Donna M. Ambrosino 275 Distinction between Parasitologic and Clinical Efficacy of 259 Disseminated Mycobacterium avium Complex Infection in Antimalarial Agents AIDS: Immunopathogenic Significance of an Activated Tom Smith Tumor Necrosis Factor System and Depressed Serum 276 Reply of 1,25 Dihydroxyvitamin D Levels Walter Weiss Charlotte 1. Haug, Pdl Aukrust, Egil Lien, Fredrik Maller, Terje Espevik, 277 Notices and Errata and Stig S. Freland Instructions for Authors

Volume 173 • Number 2 February 1996

279 Effects of Influenza A Nucleoprotein on 285 Induction of Mucosal Antibodies by Live Attenuated and Polymorphonuclear Neutrophil Function Inactivated Influenza Virus Vaccines in the Chronically III 1. Allen D. Cooper, Jr., Roxanna Carcelen, Elderly and Rachel Culbreth Geoffrey 1. Gorse, Esther E. Otto, Douglas C. Powers, Guy W. Chambers, Christopher S. Eickhoff, and Frances K. Newman 291 Differential Effects of Famciclovir and Valaciclovir on 355 Lamivudine or Stavudine in Two- and Three-Drug the Pathogenesis of Herpes Simplex Virus in a Murine Combinations against Human Immunodeficiency Virus Infection Model Including Reactivation from Latency Type 1 Replication In Vitro Alana M. Thackray and Hugh J Field Debra P. Merrill, Mona Moonis, Ting-Chao Chou, and Martin S. Hirsch 300 Patterns of Immune Responses to the Host-Encoded GOR and Hepatitis C Virus Core-Derived Epitopes with 365 Invasive Group B Streptococcal Disease: The Emergencr Relation to Hepatitis C Viremia, Genotypes, and Liver of Serotype V Disease Severity Henry M. Blumberg, David S. Stephens, Juan Antonio Quiroga, Margarita Pardo, Sonia Navas, Matthew Modansky, Melinda Erwin, John Elliot, Julio Martin, and Vicente Carreno Richard R. Facklam, Anne Schuchat, Wendy Baughman, and Monica M. Farley 306 Concurrent Oral Poliovirus and Rhesus-Human Reassortant Rotavirus : Effects on Immune 374 Spread of Multidrug-Resistant Streptococcus pneumoniae Responses to Both Vaccines and on Efficacy of Rotavirus among Hospitalized Children in Slovakia Vaccines Mary R. Reichler, Julius Rakovsky, Margaret B. Rennels, Richard L. Ward, Margarita Slacikova, Beata Hlavacova, Michael E. Mack, and Edward T Zito Ludmila Krajcikova, Peter Tarina, Alica Sobotova, for the US Rotavirus Vaccine Efficacy Group Richard R. Facklam, and Robert F. Breiman Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021

314 Protection against Papillomavirus with a Polynucleotide 380 Truncated Streptococcus pneumoniae PspA Molecules Vaccine Elicit Cross-Protective Immunity against Pneumococcal John J Donnelly, Douglas Martinez, Challenge in Mice Kathrin U Jansen, Ronald W. Ellis, Rebecca Creech Tart, Larry S. Mclianiel, Donna L. Montgomery, and Margaret A. Liu Beth A. Ralph, and David E. Briles 321 Alterations in the Immune Response of Human 387 Antibody Response to Pneumococcal Capsular Immunodeficiency Virus (HIV)-Infected Subjects Treated Polysaccharide Vaccine in the Elderly with an HIV-Specific Protease Inhibitor, Ritonavir Ulla Sankilampi, Pekka 0. Honkanen, Aini Bloigu, A. D. Kelleher, A. Carr, J Zaunders, and D. A. Cooper Elja Herva, and Maija Leinonen

330 A Dose-Ranging Study of a Prototype Synthetic HIV-I MN 394 Haemophilus ducreyi Elicits a Cutaneous Infiltrate of V3 Branched Peptide Vaccine CD4 Cells during Experimental Human Infection Geoffrey J Gorse, Michael C. Keefer, Stanley M. Spinola, Attilio Orazi, Janet N Arno, Robert B. Belshe, Thomas J Matthews, Kate Fortney, Patricia Kotylo, Cheng-Yen Chen, Bruce D. Forrest, Ray-Hahn Hsieh, Wayne C. KofJ, Anthony A. Campagnari, and Antoinette F. Hood Carl V Hanson, Raphael Dolin, Kent J Weinhold, 403 Identification of an Uncultivable Borrelia Species in the Sharon E. Frey, Nzeera Ketter, and Patricia E. Fast, Hard Tick Amblyomma americanum: Possible Agent of a for the National Institute ofAllergy and Infectious Lyme Disease-like Illness Diseases AIDS Vaccine Evaluation Group Alan G. Barbour, Gary O. Maupin, Glenna J Teltow, 340 Immunization with Envelope Subunit Vaccine Products Carol J. Carter, and Joseph Piesman Elicits Neutralizing Antibodies against Laboratory­ 410 Evidence against a Role for Interleukin-LO in Regulation Adapted but Not Primary Isolates of Human of Growth of Mycobacterium avium in Human Monocyte: Immunodeficiency Virus Type 1 Hiroe Shiratsuchi, Beverly Hamilton, Zahra Toossi, John R. Mascola, Stuart W. Snyder, Owen S. Weislow, and Jerrold J Ellner Seifu M. Belay, Robert B. Belshe, David H. Schwartz, Mary Lou Clements, Raphael Dolin, 418 The Broad-Spectrum Activity and Efficacy of Catheters Barney S. Graham, Geoffrey J Gorse, Coated with Minocycline and Rifampin Michael C. Keefer, M. Juliana McElrath, Issam Raad, Rabih Darouiche, Ray Hachem, Mary Clare Walker, Kenneth F. Wagner, Mohammad Mansouri, and Gerald P. Bodey John G. McNeil, Francine E. McCutchan, and Donald S. Burke for the National Institute 425 A Murine Model of Candida glabrata Vaginitis ofAllergy and Infectious Diseases AIDS Vaccine Paul L. Fidel, Jr., Jessica L. Cutright, Larry Tait, Evaluation Group and Jack D. Sobel

349 Relation between Changes in Cellular Load, Evolution of 432 Nitric Oxide and Host Defense against Pneumocystis Viral Phenotype, and the Clonal Composition of Virus carinii Infection in a Mouse Model Populations in the Course of Human Immunodeficiency Judd E. Shellito, Jay K. Kolls, Ruxandra Olariu, Virus Type 1 Infection and James M. Beck Maarten Koot, Angelique B. van 't Wout, Neeltje A. Kootstra, Ruud E. Y. de Goede, Matthijs Tersmette, and Hanneke Schuitemaker 440 Molecular Phylogenetic Analysis of Cyclospora, the 472 Human Immunodeficiency Virus Type I (HIV-l)­ Human Intestinal Pathogen, Suggests that It Is Closely Seronegative Injection Drug Users at Risk for HIV Related to Eimeria Species Exposure Have Antibodies to HLA Class I Antigens and David A. Reiman, Thomas M. Schmidt, Alvin Gajadhar, T Cells Specific for HIV Envelope Mitchell Sogin, John Cross, Kristine Yoder, Alberto Beretta, Stanley H. Weiss, Orntipa Sethabutr, and Peter Echeverria Giovanna Rappocciolo, Raghavan Mayur, Claudio De San tis, John Quirinale, Antonio Cosma, Concise Communications Piera Robbioni, Gene M. Shearer, 1. A. Berzofsky, Maria Luisa Villa, Antonio G. Siccardi, 446 Prognostic Significance and Risk Factors of Untreated and Mario Clerici Cytomegalovirus Viremia in Liver Transplant Recipients Andrew D. Badley, Robin Patel, Daniel F. Portela, 476 Recognition of the Highly Conserved YMDD Region in the Human Immunodeficiency Virus Type I Reverse William S. Harmsen, Thomas F. Smith, Transcriptase by HLA-A2-Restricted Cytotoxic T Duane M. llstrup, Jeffery L. Steers, Lymphocytes from an Asymptomatic Long-Term Russell H. Wiesner, and Carlos V Paya Nonprogressor 450 The Protective Effect of Immunologic Boosting against Ellen Harrer, Thomas Harrer, Peter Barbosa, Zoster: An Analysis in Leukemic Children Who Were Mark Feinberg, R. Paul Johnson, Susan Buchbinder, Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Vaccinated against Chickenpox and Bruce D. Walker Anne A. Gershon, Philip LaRussa, Sharon Steinberg, Nancy Mervish, Shaw Hwa Lo, and Paul Meier 480 Meat Grinders and Molecular Epidemiology: Two Supermarket Outbreaks of Escherichia coli 0l57:H7 453 Comparison of US Inactivated Split-Virus and Russian Infection Live Attenuated, Cold-Adapted Trivalent Influenza N. Banatvala, A. R. Magnano, M. L. Cartter, Vaccines in Russian Schoolchildren T. 1. Barrett, W F. Bibb, L. L. Vasile, P. Mshar, A. S. Khan, F. Polezhaev, R. Vasiljeva, V Drinevsky, M. A. Lambert-Fair, 1. H. Green, N. H. Bean, 1. Buffington, H. Gary, A. Sominina, W. Keitel, and R. V Tauxe H. Regnery, N. L. Lonskaya, E. Doroshenko, A. Gavrilov, J. Ivakhov, N. Arden, L. B. Schonberger, 484 Route of Infection Determines the Clinical Manifestations R. Couch, A. Kendal, and N. Cox of Acute Q Fever Thomas 1. Marrie, Andreas Stein, David Janigan, 457 Prevalence and Type of Precore Hepatitis B Virus and Didier Raoult Mutants in Hepatitis D Virus Superinfection and Its Clinical Implications 488 Effect of Pregnancy on the Risk of Developing Active Jaw-Ching Wu, Chuan-Mu Chen, Trong-Zong Chen, Tuberculosis Shou-Dong Lee, Fu-Shun Yen, and Kong-Bung Choo Marcos A. Espinal, Arthur L. Reingold, and Maria Lavandera 460 Lymphocyte Subsets, Apoptosis, and Cytokines in Patients with Chronic Fatigue Syndrome 491 Primary and Secondary Syphilis Lesions Contain mRNA Caroline M. A. Swanink, Jan H. M. M. Vercoulen, for Th I Cytokines Joep M. D. Galama, Marijke T. L. Roos, Wesley C. Van Voorhis, Lynn K. Barrett, Linde Meyaard, Johanna van der Ven-Jongekrijg, David M. Koelle, James M. Nasio, Ron de Nijs, Gijs Bleijenberg, Jan F. M. Fennis, Francis A. Plummer, and Sheila A. Lukehart Frank Miedema, and Jos W. M. van der Meer 495 Silver Iontophoretic Catheter: A Prototype of a Long­ 464 Soluble Tumor Necrosis Factor-a Receptor Type II Term Antiinfective Vascular Access Device (sTNFaRII) Correlates with Human Immunodeficiency Issam Raad, Ray Hachem, Alfonso Zermeno, Virus (HIV) RNA Copy Number in HlV-Infected Patients L. Clifton Stephens, and Gerald P. Bodey John A. Bilello, Kathleen Stellrecht. 499 Cerebrospinal Fluid Antibodies Detected by ELISA George L. Drusano, and Daniel S. Stein against a 33-kDa Antigen from Spherules of Coccidioides 468 Relationship between Infectious Cell-Associated Human immitis in Patients with Coccidioidal Meningitis Immunodeficiency Virus Type I Load, T Lymphocyte John N. Galgiani, Tao Peng, Maria L. Lewis, Subsets, and Stage of Infection in Homosexual Men Gretchen A. Cloud, Demosthenes Pappagianis, Jospeh B. Margolick, Homayoon Farzadegan, and the National Institute ofAllergy and Infectious Donald R. Hoover, and Alfred 1. Saah Diseases Mycoses Study Group

Correspondence

503 Human Cytomegalovirus Infection of Leukocyte Populations Kei Numazaki, Hideomi Asanuma, and Shunzo Chiba

503 Reply Dorothee von Laer 504 Acyclovir in Human Immunodeficiency Virus Patients 511 Reply Daniel S. Stein, Neil M H. Graham, Jean-Michel Pawlotsky, Lieven Stuyver, Lawrence P. Park, Donald R. Hoover, and Daniel Dhumeaux and Alfred J. Saah 512 Immunologic Mechanism for Human Immunodeficiency 505 Reply Virus Type 1 gp120 Vaccine Failure Joel E. Gallant, Richard D. Moore, Carol 0 'Toole, Sybille Maller, Peter Nara, and Richard E. Chaisson and Heinz Kohler

507 Inflammation in Human Immunodeficiency Virus Type I 513 Analysis of Naturally Occurring Antibodies to Mucoid Infection as a Cause of Decreased Plasma Retinol Pseudomonas aeruginosa in Cystic Fibrosis Patients Francisco J. Rosales and A. Catharine Ross Gerald B. Pier

509 Reply 514 Reply Richard D. Semba and David Vlahov Michael F. Tosi, Michael W Konstan, 509 Hepatitis C Virus Genotypes in Different Risk and Melvin Berger Populations in Spain 516 Notices and Erratum R. Bravo, V Soriano, J. Garcia-Samaniego,

J. Gonzalez, A. Castro, M Colmenero, E. Carballo, Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 A. Mas, J. Gonzdlez-Lahoz, Instructions for Authors and the Hepatitis-HIV Spanish Study Group

Volume 173 • Number 3 March 1996

IDSA Paper 550 Increased Human Immunodeficiency Virus Type I Replication in Human Peripheral Blood Mononuclear 517 Presidential Address: 33rd Annual Meeting of the Cells Induced by Ethanol: Potential Immunopathogenic Infectious Diseases Society of America: Secret Wishes Mechanisms and Selfish Desires Omar Bagasra, Suzanne E. Bachman, Lyle Jew, Vincent T Andriole Richard Tawadros, Jacqueline Cater, Guenther Boden, Isabel Ryan, and Roger J. Pomerantz Major Articles 559 Interleukin-12 Decreases Human Immunodeficiency Virus 523 Detection of Ganciclovir Resistance Mutations and Type I Replication in Human Macrophage Cultures Quantitation of Cytomegalovirus (CMV) DNA in Reconstituted with Autologous Peripheral Blood Leukocytes of Patients with Fatal Disseminated CMV Mononuclear Cells Disease Robert E. Akridge and Steven G. Reed Guy Boivin, Sunwen Chou, Mary R. Quirk, Alejo Erice, and M Colin Jordan 565 CD4 Masking during Human Immunodeficiency Virus Type I Infection, Quantified on Peripheral Blood 529 Epstein-Barr Virus DNA Recombination and Loss in Lymphocytes, Is a Potential Marker of Disease Sporadic Burkitt's Lymphoma Progression Bassem I. Razzouk, Shamala Srinivas, Clare E. Sample, Dominique Carriere, Jean-Pierre Vendrell, Vivekanand Singh, and John W Sixbey Anne-Marie Berthier, Nadine Atoui, Sharon L. Salhi, Jacques Reynes, Pierre Gros, Claude Fontaine, 536 Nucleic Acid Vaccine Encoding gD2 Protects Mice from Aline Jansen, Marie-France Huguet, Herpes Simplex Virus Type 2 Disease Laurent Ait-Cheik, and Bernard Pau John D. Kriesel, S. L. Spruance, Raymond A. Daynes, and Barbara A. Araneo 574 The Amount of Early p24 Antigenemia and Not the Time of First Detection of Virus Predicts the Clinical Outcome 542 Human Herpesvirus 8 Is Present in the Lymphoid System of Infants Vertically Infected with Human of Healthy Persons and Can Reactivate in the Course of Immunodeficiency Virus AIDS V Papaevangelou, H. Pollack, M Rigaud, B. Bigoni, R. Dolcetti, L. de Lellis, A. Carbone, N. Arlievsky, M-L. Lu, G. Rochford, K. Krasinski, M Boiocchi, E. Cassai, and D. Di Luca and W Borkowsky 579 Differences in the Incidence of Hepatitis B and Human 661 Function of Soluble CD14 in Serum from Patients with Immunodeficiency Virus Infections among Injecting Drug Septic Shock Users Regine Landmann, Anne Marie Reber, Orin S. Levine, David Vlahov, Ron Brookmeyer, Sebastiana Sansano, and Werner Zimmerli Sylvia Cohn, and Kenrad E. Nelson 669 Polymerase Chain Reaction-Based Sequence-Specific 584 Evaluation of Morbidity among Human T Lymphotropic Oligonucleotide Hybridization Analysis of HLA Class II Virus Type I Carriers in Miyazaki, Antigens in Pulmonary Tuberculosis: Relevance to Sherri 0. Stuver, Nobuyoshi Tachibana, Chemotherapy and Disease Severity Akihiko Okayama, and Nancy E. Mueller R. Rajalingam, N. K. Mehra, R. C. Jain, V P. Myneedu, and 1. N. Pande 592 A Simian Strain of Hepatitis A Virus, AGM-27, Functions as an Attenuated Vaccine for Chimpanzees 677 Treatment of Mycobacterium avium Complex Infection: Suzanne U. Emerson, Sergei A. Tsarev, Do the Results of In Vitro Susceptibility Tests Predict Sugantha Govindarajan, Max Shapiro, Therapeutic Outcome in Humans? and Robert H. Purcell Jeanette P. Sison, Yizhong Yao, Carol A. Kemper, John R. Hamilton, Elmer Brummer, David A. Stevens, 598 Treatment of Parainfluenza Virus Type 3 Bronchiolitis and Stanley C. Deresinski

and Pneumonia in a Cotton Rat Model Using Topical Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Antibody and Glucocorticosteroid 684 Identification of a Glucan-Associated Enolase as a Main Gregory A. Prince and David D. Porter Cell Wall Protein of Candida albicans and an Indirect Target of Lipopeptide Antimycotics 609 Recall of Original Serologic Response after Challenge Letizia Angiolella, Monica Facchin, with Homologous and Heterologous Chlamydia Annarita Stringaro, Bruno Maras, Nicola Simonetti, tis Serovars and Antonio Cassone Qixun Zhao, Claudia 1. Lammel, Erika A. Lindquist, and Richard S. Stephens 691 Antimalarial Drugs Reduce Cytoadherence and Rosetting of Plasmodium falciparum 619 Group A Streptococcal Bacteremia: The Role of Tumor R. Udomsangpetch, B. Pipitaporn, S. Krishna, Necrosis Factor in Shock and Organ Failure B. Angus, S. Pukrittayakamee, I. Bates, D. 1. Stevens, A. E. Bryant, S. P. Hackett, A. Chang, Y. Suputtamongkol, D. E. Kyle, and N. 1. White G. Peer, S. Kosanke, T Emerson, and 1. Hinshaw 699 Differential Expression of Chemokines in Patients with 627 Mechanisms for Mucosal Imrnunogenicity and Adjuvancy Localized and Diffuse Cutaneous American Leishmaniasis of Escherichia coli Labile Enterotoxin Uwe Ritter, Heidrun Moll, Tamas Laskay, Ichiro Takahashi, Mariarosaria Marinaro, Eva-Bettina Brocker, Oscar Velazco, Hiroshi Kiyono, Raymond 1. Jackson, Ingeborg Becker, and Reinhard Gillitzer Ichiro Nakagawa, Kohtaro Fujihashi, Shigeyuki Hamada, John D. Clements, Kenneth 1. Bast, and Jerry R. McGhee Concise Communications 636 The Pathogenesis of Gonococcal Urethritis in Men: 710 Sequence Variation of Latent Membrane Protein-l of Confocal and Immunoelectron Microscopic Analysis of Epstein-Barr Virus Strains Associated with Hairy Urethral Exudates from Men Infected with Neisseria Leukoplakia gonorrhoeae Joel M. Palefsky, Jennifer Berline, Michael A. Apicella, Margaret Ketterer, Maria-Elena Penaranda, Evelyne T. Lennette, Frank K. N. Lee, Daoguo Zhou, Peter A. Rice, Deborah Greenspan, and John S. Greenspan and Milan S. Blake 714 Cervical Abnormalities, Human Papillomavirus, and 647 The Excessive Complement Activation in Fulminant Human Immunodeficiency Virus Infections in Women in Meningococcal Septicemia Is Predominantly Caused by Malawi Alternative Pathway Activation Paolo G. Miotti, Gina A. Dallabetta, Petter Brandtzaeg, Kolbjern Hegasen, Peter Kierulf, Richard W Daniel, Joseph K. Canner, and Tom Eirik Mollnes John D. Chiphangwi, George N. Liomba, Li-Ping Yang, and Keerti V Shah 656 Ochrobactrum anthropi Meningitis in Pediatric Pericardial Allograft Transplant Recipients 718 Type-Specific Prevalence of Human Papillomavirus DNA Huan 1. Chang, John C. Christenson, Andrew T Pavia, among Jamaican Colposcopy Patients Brad D. Bobrin, Lee A. Bland, Loretta A. Carson, Carole Rattray, Howard D. Strickler, Carlos Escoffery, Matthew 1. Arduino, Punam Verma, Sonia M. Aguero, Beverly Cranston, Claudette Brown, Angela Manns, Karen Carroll, Eileen Jenkins, Judy A. Daly, Mark H. Schiffman, Joel M. Palefsky, Marion 1. Woods, and William R. Jarvis Barrie Hanchard, and William A. Blattner 722 Cutaneous Manifestations of Human T Cell Leukemia 758 rK39: A Cloned Antigen of Leishmania chagasi that Virus Type I Infection in an Experimental Model Predicts Active Visceral Leishmaniasis R. Mark Simpson, Michel Lena, Beth Schmidt Hubbard, R. Badaro, D. Benson, M. C. Eulalio, M Freire, and Thomas J Kindt S. Cunha, E. M Netto, D. Pedral-Sampaio, C. Madureira, J M Burns, R. 1. Houghton, 727 Levels of Hepatitis C Virus in Blood Donors Infected J R. David, and S. G. Reed with Different Viral Genotypes Donald B. Smith, Fiona Davidson, Peng-Lee Yap, 762 Cure of Antimony-Unresponsive Indian Visceral Helen Brown, Janice Kolberg, Jill Detmer, Leishmaniasis with Amphotericin B Lipid Complex Mickey Urdea, Peter Simmonds, and the Shyam Sundar and Henry W Murray International HCV Collaborative Study Group 765 Clinical Immunity to Plasmodium falciparum Is 731 Safety and Immunogenicity of a Combined Live Associated with Serum Antibodies to the 19-kDa Attenuated Measles, Mumps, , and Varicella C-Terminal Fragment of the Merozoite Surface Antigen, Vaccine (MMRnV) in Healthy Children PfMSP-l Barbara M Watson, Dagna S. Laufer, Barbara J Andrea F. Egan, Joanne Morris, Guy Barnish, Kuter, Brenda Staehle, and C. Jo White Stephen Allen, Brian M Greenwood, David C. Kaslow, Anthony A. Holder, and Eleanor M Riley

735 A Novel Nonpsychotropic Cannabinoid, HU-211, in the Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Treatment of Experimental Pneumococcal Meningitis 769 High Levels of Spontaneous and Parasite Antigen-Driven Roman Bass, Dan Engelhard, Victoria Trembovler, Interleukin-LO Production Are Associated with Antigen­ and Esther Shohami Specific Hyporesponsiveness in Human 739 Staphylococcus aureus Small Colony Variants Are Siddhartha Mahanty, Stacey N. Mallis, Induced by the Endothelial Cell Intracellular Milieu Manickam Ravichandran, John S. Abrams, Omar Vesga, Michael C. Groeschel, Marijke F. Otten, V. Kumaraswami, Kunthala Jayaraman, Dorothy W Brar, James M Vann, Eric A. Ottesen, and Thomas B. Nutman and Richard A. Proctor 773 Polymerase Chain Reaction-Based Assessment after 743 Augmented Production of Extracellular Superoxide by Macrofilaricidal Therapy in Onchocerca volvulus Blood Isolates of Enterococcus faecalis Infection Mark M Huycke, Wendy Joyce, and Matthew F. Wack Thomas B. Nutman, Wilson Parredes Y, 746 Defining Inoculation Conditions for the Mouse Model of Joseph Kubofcik, and Ronald H. Guderian Ascending Urinary Tract Infection that Avoid Immediate Vesicoureteral Reflux yet Produce Renal and Bladder Correspondence Infection James R. Johnson and Jennifer J Brown 777 Pneumococcal Vaccine Response in Human Immunodeficiency Virus-Infected Patients 750 Treatment of Mycobacterium avium Complex Infection: Edwin Swiatlo, Kimberly Benton, and David E. Briles Does the Beige Mouse Model Predict Therapeutic Outcome in Humans? 778 Reply Jeanette P. Sison, Yizhong Yao, Carol A. Kemper, Edward N. Janoff John R. Hamilton, Elmer Brummer, David A. Stevens, 779 Notices and Stanley C. Deresinski

754 Identification by Random Amplification of Polymorphic Instructions for Authors DNA of a Common Molecular Type of Cryptococcus neoformans neoformans in Patients with AIDS or Other Immunosuppressive Conditions Sharon C. A. Chen, Alan G. Brownlee, Tania C. Sorrell, Patricia Ruma, David H. Ellis, Tania Pfeiffer, Bryan R. Speed, and Graeme Nimmo Volume 173 • Number 4 April 1996

Major Articles 840 Combination Therapy with Didanosine and Interferon-a in Human Immunodeficiency Virus-Infected Patients: 781 Epidemiologic Linkage of Rodent and Human Hantavirus Results of a Phase 1/11 Trial Genomic Sequences in Case Investigations of Hantavirus Joseph A. Kovacs, Chris Bechtel, Pulmonary Syndrome Richard T. Davev, Jr., Judith Falloon, Brian Hjelle, Norah Torrez-Martinez, Michael A. Poli;, Robert E. Walker, Julia A. Metcalf, Frederick T. Koster, Michele Jay, Michael S. Ascher, Victoria Davey, Stephen C. Piscitelli, Michael Baseler, Ted Brown, Pamela Reynolds, Paul Ettestad, Robin Dewar, Norman P. Salzman, Henry Masur, Ronald E. Voorhees, John Sarisky, Russell E. Enscore, and H. Clifford Lane Lawrence Sands, David G. Mosley, Clare Kioski, Ralph T. Bryan, and C. Mack Sewell 849 Antiretroviral Monotherapy in Early Stage Human Immunodeficiency Virus Disease Has No Detectable 787 A University Outbreak of Gastroenteritis Due to a Small Effect on Virus Load in Peripheral Blood and Lymph Round-Structured Virus: Application of Molecular Nodes

Diagnostics to Identify the Etiologic Agent and Patterns Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Oren 1. Cohen, Giuseppe Pantaleo, Mark Holodniy, of Transmission Cecil H. Fox, Jan M. Orenstein, Steven Schnittman, Paul E. Kilgore, Ermias D. Belay, Daniel M. Hamlin, Manette Niu, Cecilia Graziosi, George N. Pavlakis, Jacqueline S. Noel, Charles D. Humphrey, Jacob Lalezari, John A. Bartlett, Roy T. Steigbigel, Howard E. Gary, Jr., Tamie Ando. Stephan S. Monroe, Jonathan Cohn, Richard Novak, Deborah McMahon, Patricia E. Kludt, David S. Rosenthal, John Bilello, and Anthony S. Fauci Jonathan Freeman, and Roger I. Glass 857 Risk Factors for Pneumococcal Disease in Human 794 Determinants of Persistent Detection of Human Immunodeficiency Virus-Infected Patients Papillomavirus DNA in the Uterine Cervix KelZv A. Gebo, Richard D. Moore, Jeanne C. Keruly, Jacques Brisson, Isabelle Bairati, Carol Morin, and Richard E. Chaisson Michel Fortier, Celine Bouchard, Andree Christen, Pascale Bernard, Michel Roy, and Alexandre Meisels 863 CD4-IgG Binding Threshold for Inactivation of Human Immunodeficiency Virus Type 1 800 DNA Immunization against Experimental Genital Herpes Ira Berkower, Howard Mostowski, Thomas E. Bull, Simplex Virus Infection and Dano Murphy Nigel Bourne, Lawrence R. Stanberry, David I. Bernstein, and Denise Lew 870 Invasive Pneumococcal Infections in Human Immunodeficiency Virus-Infected Children 808 Immune Response to Epitopes of Hepatitis C Virus Charlotte Mao, Marvin Harper, Kenneth McIntosh, (HCV) Structural Proteins in HCV-Infected Humans and Catherine Reddington, Joyce Cohen, Richard Bachur, Chimpanzees Blake Caldwell, and Ho Wen Hsu Yun-Fen Wang, Betsy Brotman, Linda Andrus, and A/fred M. Prince 877 Patterns of Virus Burden and T Cell Phenotype Are Established Early and Are Correlated with the Rate of 822 Effect of Immune Globulin on the Prevention of Disease Progression in Human Immunodeficiency Virus Experimental Hepatitis C Virus Infection Type I-Infected Persons Krzyszto(Krawczynski, Miriam 1. Alter, Michael T. Wong, Matthew 1. Dolan, Eric Kozlow, Donald L. Tankersley, Michael Beach, Robert Doe, Gregory P. Melcher, Donald S. Burke, Betty H. Robertson, Stephen Lambert, George Kuo, R. Neal Boswell, and Maryanne Vahey John E. Spelbring, Emory Meeks, Saswati Sinha, and Dorrie A. Carson 888 Properties of IgG-Binding Proteins Expressed by Streptococcus pyogenes Isolates Are Predictive of 829 Live Subgroup B Respiratory Syncytial Virus Vaccines Invasive Potential that Are Attenuated, Genetically Stable, and Immunogenic Roberta Raeder and Michael D. P. Boyle in Rodents and Nonhuman Primates James E. Crowe, Jr., Phuong T. BUi, 896 Genetic Correlates of Throat and Skin Isolates of Group Cai- Yen Firestone, Mark Connors, William R. Elkins, A Streptococci Robert M. Chanock, and Brian R. Murphy Debra E. Bessen, Christine M. Sotir, Terri L. Readdy, and Susan K. Hollingshead 901 Genetic and Phenotypic Diversity among Isolates of 971 Differential Regulation of Inducible Nitric Oxide Streptococcuspyogenes from Invasive Infections Synthase Production in Bovine and Caprine Macrophages Michael S. Chaussee, Jianzhao Liu, Dennis L. Stevens, Heiko Adler, Barbara Adler, Paola Peveri, and Joseph J Ferretti Ernst R. Werner, Helmut Wachter, Ernst Peterhans, and Thomas W Jungi 909 Effective Treatment of Multidrug-Resistant Enterococcal Experimental Endocarditis with Combinations of Cell 979 Successful Chemotherapy in Experimental Leishmaniasis Wall-Active Agents Is Influenced by the Polarity of the T Cell Response Claudia M Brandt, Mark S. Rouse, Natasha W Laue, Before Treatment Charles W Stratton, Walter R. Wilson, Gary S. Nabors and Jay P. Farrell and James M Steckelberg 914 LlAPACHE II for Predicting Course and Outcome of Concise Communications Nosocomial Staphylococcus aureus Bacteremia and Its 987 Susceptibility of Human Cytomegalovirus to Cidofovir Is Relation to Host Defense Unchanged after Limited In Vivo Exposure to Various Ed P. F. Yzerman, Helene A. M Boelens, Clinical Regimens of Drug T. J Jeroen H Tjhie, Jan A. W Kluytmans, J M Cherrington, R. Miner, M J M Hitchcock, Johan W Mouton, and Henri A. Verbrugh J P. Lalezari, and W L. Drew Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 920 A Novel Multiply Primed Polymerase Chain Reaction 992 Restriction of Hepatitis C Virus Heterogeneity during Assay for Identification of Variant papG Genes Encoding Prolonged Interferon-a Therapy in Relation to Changes in the Gal(al-4)Gal-Binding PapG Adhesins of Escherichia Virus Load coli Z. B. Yun, J Odeberg, J Lundeberg, 0. Weiland, James R. Johnson and Jennifer J Brown M osu« and A. Sonnerborg 927 Late Administration of a Lipophilic Tyrosine Kinase 997 Hepatitis in Used Syringes: The Limits of Sensitivity of Inhibitor Prevents Lipopolysaccharide and Escherichia Techniques to Detect Hepatitis B Virus (HBV) DNA, coli- Induced Lethal Toxicity Hepatitis C Virus (HCV) RNA, and Antibodies to HBV Alexey Vanichkin, Miriam Patya, Aviv Gazit, Core and HCV Antigens Alexander Levitzki, and Abraham Novogrodsky Robert Heimer, Kaveh Khoshnood, 934 Strand Displacement Amplification and the Polymerase Bini Jariwala-Freeman, Barney Duncan, Chain Reaction for Monitoring Response to Treatment in and Yvonne Harima Patients with Pulmonary Tuberculosis 1001 Presence of Human Immunodeficiency Virus (HlV) Type Tobin J Hellyer, Terry W Fletcher, Joseph H Bates, I and HIV-1-Specific Antibodies in Cervicovaginal William W Stead, Gary L. Templeton, Secretions of Infected Mothers and in the Gastric M Donald Cave, and Kathleen D. Eisenach Aspirates of their Infants 942 Disseminated Mycobacterium avium Complex: Correlation Karin Nielsen, Pamela Boyer, Maryanne Dillon, between Blood and Tissue Burden Deborah Wafer, Lian S. Wei, Eileen Garratty, Francesca J Torriani, Cynthia A. Behling, Ruth E. Dickover, and YvonneJ Bryson J Allen McCutchan, Richard H Haubrich, 1005 Polyethylene Glycol-Modified Interleukin-2 and and Diane V Havlir Thymosin al in Human Immunodeficiency Virus Type I 950 The Epidemiology of Chlamydia trachomatis within a Infection Sexually Transmitted Diseases Core Group R. Ramachandran, D. A. Katzenstein, M A. Winters, Robert C. Brunham, Joshua Kimani, Job Bwayo, S. K Kundu, and T. C. Merigan Gregory Maitha, Ian Maclean, Chunlin Yang, 1009 Analysis of Meningococcal Serogroup C- Specific Caixia Shen, Susan Roman, Nico J D. Nagelkerke, Antibody Levels in British Columbian Children and Mary Cheang, and Francis A. Plummer Adolescents 957 Failure to Detect Chlamydia pneumoniae in Coronary Leslie Ann Mitchell, Jan J Ochnio, Candice Glover, Atheromas of Patients Undergoing Atherectomy Ashley Y Lee, Margaret K-L. Ho, and Alison Bell Steven M Weiss, Patricia M. Roblin, 1014 Reactogenicity and Immunogenicity of a Protein­ Charlotte A. Gaydos, Peter Cummings, Conjugated Pneumococcal Oligosaccharide Vaccine in Dorothy L. Patton, Nancy SchulhofJ, Jacob Shani, Older Adults Robert Frankel, Keith Penney, Thomas C. Quinn, Douglas C. Powers, Edwin L. Anderson, Margaret R. Hammerschlag, and Julius Schachter Kathleen Lottenbach, and ChrisAnna M Mink 963 Surgical Site Infections Occurring after Hospital 1019 Enteroaggregative Escherichia coli Heat-Stable Discharge Enterotoxin Is Not Restricted to Enteroaggregative E. coli Kenneth Sands, Gordon Vineyard, and Richard Platt Stephen J. Savarino, Annette McVeigh, John Watson, Alejandro Cravioto, Jose Molina, Peter Echeverria, Maharaj K Bhan, Myron M Levine, and Alessio Fasano 1023 Seroprevalence to Bartonella quintana among Patients at Correspondence a Community Clinic in Downtown Seattle 1044 Randomization to Iron Supplementation of Patients with Lisa A. Jackson, David H. Spach, Deborah A. Kippen, Advanced Human Immunodeficiency Virus Disease-An Nancy K. Sugg, Russell 1. Regnery, Merlyn H. Sayers, Inadvertent but Controlled Study with Results Important and Walter E. Stamm for Patient Care 1027 Human Granulocytic Ehrlichiosis in Wisconsin and David P. Jacobus Minnesota: A Frequent Infection with the Potential for Persistence 1045 Reply 1. Stephen Dumler and Johan S. Bakken 1. 1. vu« and D. Salmon-Ceron 1030 Late Acquisition of Hyporesponsiveness to 1045 Iron and Oxidative Stress as a Mechanism for the Lipopolysaccharide by Mycobacterium avium~Infected Enhanced Production of Human Immunodeficiency Virus Human Macrophages in Producing Tumor Necrosis by Alveolar Macrophages from Otherwise Healthy Factor-a but Not Interleukin-l,8 and -6 Cigarette Smokers Lanfranco Fattorini, Yan Xiao, Clara M. Ausiello, Johan R. Boelaert, Jacques Piette, Francesca Urbani, Andrea laSala, Maurizio Mattei, Geoffrey A. Weinberg, Christine Sappey, and Graziella Orefici and Eugene D. Weinberg Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 1034 Pneumocystis carinii Infection in Transgenic B Cell ~ 1046 Reply Deficient Mice Elizabeth A. Rich and Rita A. Abbud Harold Marcotte, Denise Levesque, Kathleen Delanay, Andree Bourgeault, Roger de la Durantaye, 1047 Transplacental IgG Anti~Haemophilus influenzae Type b Steve Brochu, and Marc C. Lavoie Transfer in Mexican Mothers of a Low Socioeconomic Level 1038 Genetic Evidence for Latent Septata intestinalis Infection Araceli Paez, Vicente Ruiz, Teresa Ramirez, Virus~ in Human Immunodeficiency Infected Patients Felipe Masso, Luis E. Salmon, and Luis F. Montano with Intestinal Microsporidiosis Caspar Franzen, RalfKiippers, Andreas Maller, 1049 Importance of Using Markers of Dilution When Bernd Salzberger, Gerd Fiitkenheuer, Britta Vetten, Measuring Inflammatory Mediators in Nasal Lavage Fluid Volker Diehl, and Matthias Schrappe [an Balfour-Lynn 1041 Models of Relapse of Experimental Visceral Leishmaniasis 1050 Reply Henry W. Murray, June Hariprashad, Terry L. Noah and Richard E. Fichtl

Volume 173 • Number 5 May 1996

Major Articles 1077 Placental Transfer and Maternally Acquired Neonatal IgG Immunity in Human Immunodeficiency Virus Infection 1051 Analysis of T Helper Cell Response to Glycoprotein H M. Isabel de Moraes-Pinto, Ana C. M. Almeida, (gpUL75) of Human Cytomegalovirus: Evidence for Grecy Ken}, Thomaz E. Filgueiras, Wanda Tobias, Strain-Specific T Cell Determinants Amelia M. N. Santos, Magda M. S. Carneiro-Sampaio, Jochen Beninga, Hubert Kalbacher, and Michael Mach Cali! K. Farhat, Paul1. M. Milligan, Peter M. Johnson, 1062 Neutralization of Human Cytomegalovirus by Human and Charles A. Hart CD13-Specific Antibodies 1085 In Vitro Restoration of T Cell Immune Function in Terrence D. Giugni, Cecilia Soderberg, Debby 1. Ham, Human Immunodeficiency Virus-Positive Persons: Robert M. Bautista, Kjell-OlofHedlund, Erna Moller, Effects of Interleukin (IL)-12 and Anti-Tb-Iu and John A. Zaia Alan 1. Landay, Mario Clerici, Farah Hashemi, 1072 Time to Detection of Cytomegalovirus (CMV) DNA in Harold Kessler, Jay A. Berzofsky, and Gene M. Shearer Blood Leukocytes Is a Predictor for the Development of 1092 Changes in Biologic Phenotype of Human CMV Disease in CMV-Seronegative Recipients of Immunodeficiency Virus during Treatment of Patients Allografts from CMV-Seropositive Donors following with Didanosine Liver Transplantation N. N. Zheng, P. W. McQueen, 1. Hurren, 1. A. Evans, Rafael Manez, Shimon Kusne, Charles Rinaldo, M. G. Law, S. Forde, S. Barker, D. A. Cooper, Jose Maria Aguado, Kirsten Sf. George, Paolo Grossi, and S. F. Delaney Bonnie Frye, John 1. Fung, and Garth D. Ehrlich 1097 Randomized Study of the Tolerance and Efficacy of 1157 A Noncova1ent Complex Vaccine Prepared with High- versus Low-Dose Zidovudine in Human Detoxified Escherichia coli J5 (Rc Chemotype) Immunodeficiency Virus-Infected Children with Mild to Lipopolysaccharide and Neisseria meningitidis Group B Moderate Symptoms (AIDS Clinical Trials Group 128) Outer Membrane Protein Produces Protective Antibodies Michael T. Brady, Nuala McGrath, Pim Brouwers, against Gram-Negative Bacteremia Richard Gelber, Mary Glenn Fowler, Ram Yogev, Apurba K. Bhattacharjee, Steven M. Opal, Nancy Hutton, Yvonne J. Bryson, Charles D. Mitchell, Robert Taylor, Robert Naso, Mark Semenuk, Senih Fikrig, William Borkowsky, Eleanor Jimenez, Wendell D. Zollinger, Ellen E. Moran, Lynnette Young, George McSherry, Arye Rubinstein, Craig Hammack, Jerald C. Sadoff, and Alan S. Cross Catherine M. Wilfert, Kenneth McIntosh, 1164 Comparison of the Effects of Shiga-like Toxin 1 on Mary Maha Elkins, Peggy S. Weintrub, Cytokine- and Butyrate-Treated Human Umbilical and and the Pediatric AIDS Clinical Trials Group Saphenous Vein Endothelial Cells 1107 Phase I Trial of Interferon Alfa-n3 in Early-Stage Human Gerald T. Keusch, David W. K. Acheson, Immunodeficiency Virus Type 1 Disease: Evidence for Leonie Aaldering, John Erban, and Mary S. Jacewicz Drug Safety, Tolerance, and Antiviral Activity 1171 The Interrelationship between Cytotoxin-Associated Gene Donald R. Skillman, Joseph L. Malone, A, Vacuolating Cytotoxin, and Helicobacter pylori­ Catherine F. Decker, Kenneth F. Wagner, Related Diseases Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Robert L. Mapou, Mei-June Liao, Douglas Testa, Jan F. L. Weel, Rene W. M. van der Hulst, and Monte S. Meltzer Yvette Gerrits, Philip Roorda, Monique Feller, 1115 The Association of Antibodies against Human T Cell Jacob Dankert, Guido N. J. Tytgat, Lymphotropic Virus Type I (HTLV-I) pX Gene Mutant and Arie van der Ende Products with HTLV-I- Associated Myelopathy/Tropical 1176 The Epidemiology of Vibrio Infections in Florida, 1981­ Spastic Paraparesis 1993 Jun Suzuki, Jun-ichi Kira, Eishi Baba, W. Gary Hlady and Karl C. Klontz Minoru Nakamura, Yoshio Koyanagi, Tatsufumi Nakamura, Yuji Kawano, Kenji Yamasaki, 1184 A Flagella-less Mutant of Borrelia burgdorferi as a Live Susumu Shirabe, Naoya Hatano, Kenshi Hayashi, Attenuated Vaccine in the Murine Model of Lyme Naoki Yamamoto, and Takuro Kobayashi Disease Ariadna Sadiiene, Patricia A. Thompson, 1123 Passive and Active Immunotherapy for Experimental and Alan G. Barbour Pneumococcal Pneumonia by Polyvalent Human Immunoglobulin or Ftab'), Fragments Administered 1194 Multinucleated Giant Cell Formation of Swine Microglia Intranasally Induced by Mycobacterium bovis Francoise Ramisse, Patrice Binder, Marek Szatanik, Phillip K. Peterson, Genya Gekker, Shuxian Hu, and Jean-Michel Alonso W. Robert Anderson, Matthew Teichert, Chun C. Chao, and Thomas W. Molitor 1129 Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide­ 1202 Phagocytosis and Intracellular Killing of Candida Resistant Enterococci albicans by Macrophages Exposed to Myeloperoxidase Philippe Van der Auwera, Nelly Pensart, Volkan Korten, Stanley S. Lefkowitz, Monique P. Gelderman, Barbara E. Murray, and Roland Leclercq Doris L. Lefkowitz, Nicole Moguilevsky, and Alex Bollen 1137 Interaction of Haemophilus infiuenzae with the 1208 Phase I Study of Amphotericin B Colloidal Dispersion for Mammalian Extracellular Matrix the Treatment of Invasive Fungal Infections after Marrow Ritva Virkola, Kaarina Ldhteenmdki, Thomas Eberhard, Transplant Pentti Kuusela, Loek van Alphen, Mans Ullberg, Raleigh A. Bowden, Monica Cays, Ted Gooley, and Timo K. Korhonen Richard D. Mamelok, and Jo-Anne van Burik

1148 The Relationship between Plasminogen Activator 1216 Treatment of Experimental Cryptococcal Meningitis with Inhibitor-1 and Proinflammatory and Counterinflammatory Fluconazole: Impact of Dose and Addition of Flucytosine Mediators in Children with Meningococcal Septic Shock on Mycologic and Pathophysiologic Outcome Rene F. Kornelisse, Jan A. Hazelzet, Marinka Kartalija, Keith Kaye, Jay H Tureen, Huub F. J. Savelkoul, Wim C.J. Hop, Marja H. Suur, Qingxiang Liu, Martin G. Tauber, Berkley R. Elliott, Alexander N. J. Borsboom, Inge M. Risseeuw-Appel, and Merle A. Sande Edwin van der Voort, and Ronald de Groot 1222 1774 Murine Macrophage-like Cell Interactions with Cryptococcus neoformans in the Presence and Absence of Opsonins Sushovita Mukherjee, Marta Feldmesser, and Arturo Casadevall 1232 Antibody Response Patterns against Schistosoma mansoni 1277 Elevations in Granulocyte-Macrophage Colony­ in a Recently Exposed Community in Senegal Stimulating Factor and Interleukin-5 Levels Precede Govert1. van Dam, Foekje F. Stelma, Bruno Gryseels, Posttreatment Eosinophilia in Sonja T. M. Falcao Ferreira, I. Talla, M. Niang, John B. Hagan, Kathleen R. Bartemes, Hirohito Kita. 1. Peter Rotmans, and Andre M. Deelder Eric A. Ottesen, Kwablah Awadzi, Thomas B. Nutman, and Gerald1. Gleich 1242 Antischistosome IgG4 and IgE Responses Are Affected Differentially by Chemotherapy in Children versus Adults 1281 Big Endothelin in Patients with Complicated Plasmodium Jane L. Grogan, Peter G. Kremsner, Govert 1. van Dam, falciparum Malaria Wolfram Metzger, Benjamin Mordmuller, Christoph Wenisch, Heidi Wenisch, Polrat Wilairatana, Andre M. Deelder, and Maria Yazdanbakhsh Sornchai Looareesuwan, Suparp Vannaphan, Oswald Wagner, Wolfgang Graninger, Eva Schonthal, Concise Communications and Helmut Rumpold 1248 Immunologic Properties of Epstein-Barr Virus­ 1284 Field Evaluation of a Polymerase Chain Reaction-Based Seronegative Adults Nonisotopic Liquid Hybridization Assay for Malaria W. 1. Jabs, H. 1. Wagner, P. Neustock, H. Kluter, Diagnosis and H. Kirchner Denise A. Oliveira, Ya P. Shi, Aggrey1. 0100, David A. Boriga, Bernard L. Nahlen, Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 1252 Effect of Stavudine on Human Immunodeficiency Virus William A. Hawley, Brian P. Holloway, and AltafA. Lal Type 1 Virus Load as Measured by Quantitative Mononuclear Cell Culture, Plasma RNA, and Immune Complex- Dissociated Antigenemia Correspondence Brigitte P. Griffith, Helena Brett-Smith, Grace Kim, 1288 Coccoid Forms of Helicobacter pylori John W. Mellors, Thomas M. Chacko, Robin B. Garner, Luigina Cellini Yung-chi Cheng, Philip Alcabes, and Gerald Friedland 1288 Reply 1256 The Seroepidemiology of Bordetella pertussis Infections: Kathryn A. Eaton, Carl E. Catrenich, Kelly M. Makin, A Study of Persons Ages 1-65 Years and Steven Krakowka Laura A. Cattaneo, George W. Reed, David H. Haase, Morgan 1. Wills, and Kathryn M. Edwards 1289 Comparison of Cotton and Rayon/Cotton Tampons for Efficacy of Toxic Shock Syndrome Toxin-l Production 1260 The Public Health Impact of Lyme Disease in Maryland Philip M. Tierno, Jr. Bonnie S. Coyle, G. Thomas Strickland, Yale Y. Liang, Cesar Peiia, Robert McCarter, and Ebenezer 1290 Reply Patrick M. Schlievert 1263 Staphylococcal Food Poisoning Caused by Imported Canned Mushrooms 1292 Relative Importance of Oral versus Intravenous William C. Levine, Reginald W. Bennett, Vancomycin Exposure in the Development of Youngsook Choi, Kelly 1. Henning, Judith R. Rager, Vancomycin-Resistant Enterococci Katherine A. Hendricks, David P. Hopkins, Andrew D. Luber, Richard A. Jacobs, Marilyn Jordan, Robert A. Gunn, and Patricia M. Griffin and B. Joseph Guglielmo

1267 T Lymphocytic and Immature Macrophage Alveolitis in 1293 Reply Active Pulmonary Tuberculosis David K. Shay, William R. Jarvis, and S. K. Schwander, E. Sada, M. Torres, D. Escobedo, Marisa Montecalvo 1. G. Sierra, S. Alt, and E. A. Rich 1294 Folinic Acid Supplements to Pyrimethamine-Sulfadiazine 1273 Detection of Coccidioidal Antibodies by 33-kDa Spherule for Toxoplasma Encephalitis Are Associated with Better Antigen, Coccidioides EIA, and Standard Serologic Tests Outcome in Sera from Patients Evaluated for Coccidioidomycosis Christian Van Delden and Bernard Hirschel Marion A. Wieden, Linda L. Lundergan, Jay Blum, 1296 Notices Kathy L. Delgado, Rosario Coolbaugh, Ray Howard, Tao Peng, Evelyn Pugh, Norma Reis, Jerry Theis, and John N. Galgiani Instructions for Authors Volume 176 • Number 6 June 1996

Major Articles 1347 IgG Antibody to Pneumococcal Capsular Polysaccharide in Human Immunodeficiency Virus-Infected Subjects: 1297 Hantavirus Pulmonary Syndrome: The First 100 US Cases Persistence of Antibody in Responders, Revaccination in Ali S. Khan, Rima F. Khabbaz, Lori R. Armstrong, Nonresponders, and Relationship of Immunoglobulin Robert C. Holman, Sally P. Bauer, Judith Graber, Allotype to Response Tara Strine, Gayle Miller, Susan Reef, Jordan Tappero, Maria C. Rodriguez-Barradas, Jean E. Groover, Pierre E. Rollin, Stuart T. Nichol, SherifR. Zaki, Christine E. Lacke, Dieter W. Gump, Ralph T. Bryan, Louisa E. Chapman, C. J. Peters, Christopher J Lahart, Janardan P. Pandey, and Thomas G. Ksiazek and Daniel M. Musher 1304 Quantitation of Cytomegalovirus DNA and 1354 Virologic and Immunologic Benefits of Initial Characterization of Viral Gene Expression in Combination Therapy with Zidovudine and Zalcitabine or Bronchoalveolar Cells of Infected Patients with and Didanosine Compared with Zidovudine Monotherapy without Pneumonitis Robert T. Schooley, Carlos Ramirez-Ronda, Guy Boivin, Carol A. Olson, Mary R. Quirk, Joep M. A. Lange, David A. Cooper, James Lavelle, Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Barbara Kringstad, Marshall I. Hertz, Lewis Lefkowitz, Mark Moore, Brendan A. Larder, and M. Colin Jordan Marty St. Clair, Jan Willem Mulder, Ray Mckinnis, 1313 Evaluation of Live Attenuated Influenza Vaccines in Kevin N. Pennington, P. Richard Harrigan, Children 6-18 Months of Age: Safety, Immunogenicity, Ian Kinghorn, Helen Steel, James F. Rooney, and the and Efficacy Wellcome Resistance Study Collaborative Group William C. Gruber, Robert B. Belshe, James C. King, 1367 Human Immunodeficiency Virus-Induced Cell Death in John J Treanor, P. A. Piedra, Peter F. Wright, Cytokine-Treated Macrophages Can Be Prevented by George W. Reed, Edwin Anderson, and Fran Newman Compounds that Inhibit Late Stages of Viral Replication for the National Institute ofAllergy and Infectious Alberto Bergamini, Luciana Dini, Marcella Capozzi, Diseases Vaccine and Treatment Evaluation Program Lina Ghibelli, Roberta Placido, Emanuela Faggioli, and the Wyeth-Ayerst ca Influenza Vaccine Agata Salanitro, Elena Buonanno, Luisa Cappannoli, Investigators Group Laura Ventura, Mario Cepparulo, Laura Falasca, and 1320 The Effect of Edmonston-Zagreb and Schwarz Measles Giovanni Rocchi Vaccines on Immune Responses in Infants 1379 In Vivo Resistance to a Human Immunodeficiency Virus Gregory D. Hussey, Elizabeth A. Goddard, Type I Proteinase Inhibitor: Mutations, Kinetics, and Jane Hughes, Judith J Ryon, Mustaphah Kerran, Frequencies Edgar Carelse, Peter M. Strebel, Lauri E. Markowitz, Helmut Jacobsen, Markus Hdnggi, Michael Ott, John Moodie, Peter Barron, Zainub Latief, Ian B. Duncan, Samantha Owen, Massimo Andreoni, RauoffSayed, David Beatty, and Diane E. Griffin Stefano Vella, and Jan Mous 1327 Vaccination of Pregnant Macaques Protects Newborns 1388 Prognostic Value of Viremia in Patients with Long- against Mucosal Simian Immunodeficiency Virus Standing Human Immunodeficiency Virus Infection Infection Annick Galetto-Lacour, Sabine Yerly, Koen K. A. Van Rompay, Moses G. Otsyula, Thomas V. Perneger, Christophe Baumberger, Ross P. Tarara, Don R. Canfield, Bernard Hirschel, Luc Perrin, and the Christopher J Berardi, Michael B. McChesney, Swiss HIV Cohort Study Group and Marta 1. Marthas 1394 Seropositivities to Human Papillomavirus Types 16, 18, 1336 A Randomized, Placebo-Controlled Study of the or 33 Capsids and to Chlamydia trachomatis Are Markers Immunogenicity of Human Immunodeficiency Virus (HIV) of Sexual Behavior rgpl60 Vaccine in HIV-InfectedSubjects with ~400/mm3 Joakim Dillner, Ingegerd Kallings, Christina Brihmer, CD4 T Lymphocytes (AIDS Clinical Trials Group Protocol Bo Sikstrom, Pentti Koskela, Matti Lehtinen, 137) John T. Schiller, Martin Sapp, and Per Anders Mdrdh Fred T. Valentine, Smriti Kundu, Patrick A. J Haslett, David Katzenstein, Laurel Beckett, Cathie Spino, 1399 Streptococcal Pyrogenic Exotoxin A Release, Distribution, Michael Borucki, Margarita Vasquez, Gale Smith, and Role in a Murine Model of Fasciitis and Multiorgan Joyce Korvick, Jonathan Kagan, Failure Due to Streptococcus pyogenes and Thomas C. Merigan Shiranee Sriskandan, David Moyes, Lee K. Buttery, Thomas Krausz, Thomas J Evans, Julia Polak, and Jonathan Cohen 1408 phoP/phoQ-Deleted Salmonella typhi (Ty800) Is a Safe 1470 Comparative Detection of Measles-Specific IgM in Oral and Immunogenic Single-Dose Typhoid Fever Vaccine in Fluid and Serum from Children by an Antibody-Capture Volunteers IgM EIA Elizabeth L. Hohmann, Carmen A. Oletta, Rita F. Helfand, Senait Kebede, James P. Alexander, Jr., Kevin P. Killeen, and Samuel 1. Miller Wondimagegnehu Alemu, Janet L. Heath, Howard E. Gary, Jr., Larry 1. Anderson, Hagos Beyene, 1415 Potential Hazards of Combination Immunotherapy in the and William 1. Bellini Treatment of Experimental Septic Shock Steven M Opal, Alan S. Cross, Jhung W Jhung, 1474 Hepatitis Band C Virus Serologies among Japanese Lynnette D. Young, John E. Palardy, Americans with Hepatocellular Carcinoma Nicholas A. Parejo, and Curtis Dansky Abraham Nomura, Grant N Stemmermann, Po-Huang Chyou, and Edward Tabor 1422 Sialylation Lessens the Infectivity of Neisseria gonorrhoeae MSII mkC 1477 Use of Antiherpes Drugs and the Risk of Kaposi's Herman Schneider, Katherine A. Schmidt, Sarcoma: Data from the Multicenter AIDS Cohort Study Donald R. Skillman, Lillian Van De Verg, Marshall 1. Glesby, Donald R. Hoover, Shigui Weng, Richard L. Warren, Hugh 1. Wylie, Jerald C. Sadoff, Neil M. H. Graham, John P. Phair, Roger Detels, Carolyn D. Deal, and Alan S. Cross Manto Ho, and Alfred 1. Saah Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 1428 Oral Immunization with the B Subunit of the Heat-Labile 1481 Polyradiculopathy Associated with Ganciclovir-Resistant Enterotoxin of Escherichia coli Induces Early Th1 and Cytomegalovirus in an AIDS Patient: Phenotypic and Late Th2 Cytokine Expression in Peyer's Patches Genotypic Characterization of Sequential Virus Isolates Ichiro Nakagawa, Ichiro Takahashi, Hiroshi Kiyono, Irene L. Smith, Mika Shinkai, William R. Freeman, and Jerry R. McGhee, and Shigeyuki Hamada Stephen A. Spector

1437 Risk Factors for Chlamydia trachomatis Pelvic 1485 Dynamics of Virus versus Host Interaction in Children Inflammatory Disease among Sex Workers in Nairobi, with Human Immunodeficiency Virus Type 1 Infection Kenya Shizuko Sei, Hiroya Akiyoshi, Jordana Bernard, Joshua Kimani, Ian W Maclean, Job 1. Bwayo, David 1. Venzon, Cecil H. Fox, Kelly MacDonald, Julius Oyugi, Gregory M. Maitha, Douglas 1. Schwartzentruber, Barry D. Anderson, Rosanna W Peeling, Mary Cheang, JejJrey B. Kopp, Brigitta U. Mueller, Nicolaas 1. D. Nagelkerke, Francis A. Plummer, and Philip A. Pizzo and Robert C. Brunham 1490 Seasonal Variation of Disseminated Penicillium marnejJei 1445 Detection of Mycoplasma pneumoniae by Two Infections in Northern Thailand: A Clue to the Reservoir? Polymerase Chain Reactions and Role of M. pneumoniae Suwat Chariyalertsak, Thira Sirisanthana, in Acute Respiratory Tract Infections in Pediatric Patients Khuanchai Supparatpinyo, and Kenrad E. Nelson M. leven, D. Ursi, H. Van Bever, W Quint, 1493 Diphtheria Antitoxin Levels in US Blood and Plasma H. G. M. Niesters, and H. Goossens Donors 1453 The Presence or Absence of Active Infection, Not Rajesh K. Gupta, Paul Griffin, Jr., Jin Xu, Clinical Status, Is Most Closely Associated with Cytokine Rachel Rivera, Claudette Thompson, Responses in Lymphatic Filariasis and George R. Siber Adriana B. de Almeida, Maria Carmelita Maia e Silva, 1498 Interleukin-lO and Soluble Tumor Necrosis Factor Maria Amelia Maciel, and David O. Freedman Receptors in Cerebrospinal Fluid of Children with 1460 Enhancement of Schistosoma mansoni Infectivity by Bacterial Meningitis Intradermal Injections of Larval Extracts: A Putative Role R. F. Kornelisse, H. F. 1. Savelkoul, P. H. G. Mulder, for Larval Proteases M. H. Suur, P. 1. C. van der Straaten, Padraic G. Fallon, Mauro M. Teixeira, Carl M. Neice, A. 1. van der Heijden, R. N Sukhai, K. Hiihlen, Timothy 1. Williams, Paul G. Hellewell, H. 1. Neijens, and R. de Groot and Michael 1. DoenhojJ 1502 Vitamin C for the Treatment of Recurrent Furunculosis in Patients with Impaired Neutrophil Functions Concise Communications R. Levy, 0. Shriker, A. Porath, K. Riesenberg, 1467 Evaluation of a Recombinant Hemagglutinin Expressed in and F. SchlaejJer Insect Cells as an Influenza Vaccine in Young and 1506 Long-Term Malaria Chemoprophylaxis with Mefloquine Elderly Adults in Dutch Marines in Cambodia John 1. Treanor, Robert F. Betts, Gale E. Smith, Adriaan P. C. C. Hopperus Buma, Edwin L. Anderson, Craig S. Hackett, Pieter P. A. M. van Thiel, Hans O. Lobel, Colin Ohrt, Bethanie E. Wilkinson, Robert B. Belshe, Eric 1. C. van Ameijden, Ron L. Veltink, and Douglas C. Powers Dick C. H. Tendeloo, Tom van Goal, Mark D. Green, Glenn D. Todd, Dennis E. Kyle, and Piet A. Kager 1510 Evaluation of a Polymerase Chain Reaction-Based Assay 1523 Reply for Diagnosis of Wuchereria bancrofti Infection Arthur E. Brown, Maryanne T Vahey, James S. McCarthy, Min Zhong, Ramya Gopinath, Susan Y. J Zhou, Raymond C. Y. Chung, Eric A. Ottesen, Steven A. Williams, Nancy M. Ruiz, David Hofheinz, James R. Lane, and Thomas B. Nutman Douglas L. Mayers, Clifton A. Hawkes, and Joseph L. Malone 1515 Interleukin-12 Restores Interferon-y Production and Cytotoxic Responses in Visceral Leishmaniasis 1524 Relevance of Plasma Protein Binding to the Antiviral Olivia Bacellar, Claudia Brodskyn, Activity and Clinical Efficacy of Inhibitors of Human Jaqueline Guerreiro, Manoel Barral-Netto, Immunodeficiency Virus Protease Carlos Henrique Costa, Robert L. Coffman, John A. Bilello and George L. Drusano Warren D. Johnson, and Edgar M. Carvalho 1525 Reply David J Livingston, S. Pazhanisamy, Correspondence Judith A. Partaledis, and Roger D. Tung 1519 Chlamydia pneumoniae and Atherosclerotic Plaque 1526 Rapid Progression to Human Immunodeficiency Virus Javier Casas-Ciria and Manuel A. Rodriguez-Iglesias Type 1 Disease Noah Jamie Robinson 1519 Reply Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Lee Ann Campbell, Edward O'Brien, 1527 Epidemiologic and Diagnostic Studies of Patients with Alison L. Cappuccio, Cho-chou Kuo, San-pin Wang, Suspected Early Lyme Disease, Missouri, 1990-1993 Douglas Stewart, Dorothy L. Patton, Edwin J. Masters and H. Denny Donnell Peter K. Cummings, and J Thomas Grayston 1528 Reply 1520 Risk Factors for Susceptibility to Heterosexual Human Grant L. Campbell, Martin E. Schriefer, Immunodeficiency Virus Infection in Women Robert B. Craven, and David T Dennis Nigel O'Farrell 1529 Errata 1521 Reply Nancy S. Padian, Judith Abrams, Joan H. Skurnick, 1530 Books Received Nancy L. Van Devanter, and Thomas R. 0 'Brien

1522 Relationship between Immune Complex-Dissociated p24 1531 Reviewers of Volume 173 Antigen and Human Immunodeficiency Virus Type I RNA Titers in Plasma 1534 Index to Volume 173 Alain Lafeuillade, Cecile Poggi, Catherine Tamalet, and Nerina Profizi Volume Contents 1534

INDEX TO VOLUME 173

Author Index Aukrust, P., 259 Benowitz, N. B., 273 Bravo, F. J., I Ausiello, C. M., 1030 Benson, D., 758 Bravo, R., 509 Aaby, P., 245 Auwaerter, P. G., 237 Benton, K., 777 Breiman, R. F., 374 Aaldering, L., 1164 Awadzi, K., 1277 Berardi, C. J., 1327 Brett-Smith, H., 1252 Abbud, R. A., 1046 Baba, E., 1115 Beretta, A., 472 Brihmer, c., 1394 Abrams, E. 1., 68 Bacellar, 0., 1515 Bergamini, A., 1367 Briles, D. E., 380, 777 Abrams, J., 1521 Bachman, S. E., 550 Berger, M., 514 Brisson, J., 794 Abrams, J. S., 769 Bachur, R., 870 Bergeron-Lynn, G., 18 Brochu, S., 1034 Acheson, D. W. K., 1164 Badaro, R., 758 Berkower, I., 863 Brocker, E.-B., 699 Adler, B., 971 Badley, A. D., 446 Berline, J., 710 Brodskyn, c, 1515 Adler, H., 971 Bagasra, 0., 550 Berman, P. W., 52 Brookmeyer, R., 579 Aguado, J. M., 1072 Bairati, I., 794 Bernard, J., 1485 Brotman, B., 808

Aguero, S. M., 656 Baker, C. J., 142 Bernard, P., 794 Brouwers, P., 1097 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Ahlm, C., 38 Bakken, J. S., 1027 Bernstein, D. I., I, 800 Brown, A. E., 1523 Ahmed, F., 83 Bakshi, S., 68 Berry, N., 245 Brown, B. W., 265 Ait-Cheik, L., 565 Balfour-Lynn, 1., 1049 Berthier, A.-M., 565 Brown, c, 718 Akiyoshi, H., 1485 Bamji, M., 68 Berzofsky, J. A., 24, 472, 1085 Brown, D., 32 Akridge, R. E., 559 Banatvala, N., 480 Besen, G., 18 Brown, H., 727 Alcabes, P., 1252 Barbosa, P., 476 Bessen, D. E., 896 Brown, J. J., 746, 920 Alemu, W., 1470 Barbour, A. G., 403, 1184 Betts, R. F., 1467 Brown, T., 781 Alexander, J. P., Jr., 1470 Barker, S., 1092 Beyene, H., 1470 Brownlee, A. G., 754 Ali, M., 226 Barnish, G., 765 Bhan, M. K., 1019 Brummer, E., 677, 750 Allen, S., 765 Barral-Netto, M., 1515 Bhatnagar, P. K., 203 Brunham, R. C., 950, 1437 Almeida, A. C. M., 1077 Barrett, L. K., 491 Bhattacharjee, A. K., 1157 Bryan, R. T., 1297, 781 Almquist, J. R., 180 Barrett, T. J., 480 Bibb, W. F., 480 Bryant, A. E., 619 Alonso, J.-M., 1123 Barron, P., 1320 Bigoni, B., 542 Bryson, Y. J., 1001, 1097 Alt, S., 1267 Bartemes, K. R., 1277 Bilello, 1. A., 464, 849, 1524 Buchbinder, S., 476 Alter, M. J., 822 Bartlett, J. A., 849 Bilska, M., 60 Buffington, 1., 453 Ambrosino, D. M., 256 Baseler, M., 840 Binder, P., 1123 Bui, P. T., 829 Anderson, B. D., 1485 Bass, R., 735 Blake, M. S., 636 Bull, T. E., 863 Anderson, E. L., 1014, 1313, Bates, I., 691 Bland, L. A., 656 Burna, A. P. C. C. H., 1506 1467 Bates, 1. H., 934 Blattner, W. A., 718 Buonnano, E., 1367 Anderson, L. J., 1470 Bauer, S. P., 1297 Bleijenberg, G., 460 Burke, D. S., 877 Anderson, W. R., 1194 Baughman, W., 365 Bloigu, A., 387 Burke, D. S. for the National Ando, T., 787 Baumberger, c., 1388 Blum, J., 1273 Institute of Allergy and Andreoni, M., 1379 Bautista, R. M., 1062 Blumberg, H. M., 365 Infectious Diseases AIDS Andriole, V. T., 517 Beach, M., 822 Bobrin, B. D., 656 Vaccine Evaluation Group, Andrus, L., 808 Bean, N. H., 480 Boden, G., 550 340 Angiolella, L., 684 Beatty, D., 1320 Bodey, G. P., 418, 495 Bums, 1. M., 758 Angus, B., 691 Bechtel, C., 840 Boelaert, J. R., 1045 Burton, A., 237 ANRS 005-ACTG 154 Group Beck, J. M., 432 Boelens, H. A. M., 914 Bussiere, J., 52 Members, 91 Becker, I., 699 Boiocchi, M., 542 Buttery, L. K., 1399 Apicella, M. A., 636 Beckett, L., 1336 Boivin, G., 523, 1304 Buurman, W. A., 252 Araneo, B. A., 536 Behling, C. A., 942 Bollen, A., 1202 Bwayo, J. J., 950, 1437 Araujo, M. I., 269 Belasco, D., 187 Bonomo, R. A., 151 Caldwell, B., 870 Arden, N., 453 Belay, E. D., 787 Boriga, D. A., 1284 Campagnari, A. A., 394 Arduino, M. J., 656 Belay, S. M., 340 Borkowsky, W., 574, 1097 Campbell, G. L., 1528 Arichi, T., 24 Bell, A., 1009 Borsboom, A. N. J., 1148 Campbell, L. A., 1519 Ariyoshi, K., 245 Bellini, W. J., 32, 1470 Borucki, M., 1336 Canfield, D. R., 1327 Arlievsky, N., 574 Belshe, R. B., 330, 340, 1467 Bost, K. L., 627 Canner, J. K., 714 Armstrong, L. R., 1297 Belshe, R. B. for the National Boswell, R. N., 877 Capozzi, M., 1367 Arno, 1. N., 394 Institute of Allergy and Bouchard, c, 794 Cappannoli, L., 1367 Asanuma, H., 503 Infectious Diseases Vaccine Bourgeault, A., 1034 Cappuccio, A. L., 1519 Ascher, M. S., 781 and Treatment Evaluation Bourne, N., I, 800 Carabaiia, J., 32 Assil, K. K., 18 Program, 1313 Bowden, R. A., 1208 Carballo, E., 509 Atoui, N., 565 Beninga, 1., 1051 Boyer, P., 1001 Carbone, A., 542 Aubertin, J., 91 Bennett, R. W., 1263 Boyle, M. D. P., 104, 888 Carcelen, R., 279 Brady, M. T., 1097 Carelse, E., 1320 Brandt, C. M., 909 Carias, L. L., 151 Brandtzaeg, P., 647 Carneiro-Sampaio, M. M. S., The Journal ofInfectious Diseases 1996;173:1534-40 Brar, D. W., 739 1077 JID 1996; 173 (June) Reviewers 1533

Michael Para Luigi Roffi Gregory T. Spear Mike Vasil Julie Parsonnet Sergio Romagnani Deborah H. Spector Abraham Verghese Thomas F. Patterson Luigina Romani Stephen A. Spector Jan Verhoef John T. Patton Clio Rooney Stanley M. Spinola Sten Vennund Carlos V. Paya Barry T. Rouse Brian G. Spratt Timo Vesikari Rosanna Peeling John M. Routes Steven C. Springmeyer Govinda S. Visvesvara Philip Pellett Craig Rubens Spotswood L. Spruance Paul Volberding John R. Perfect David Russell Joseph W. St. Geme III Girish N. Vyas David H. Perlmutter Thomas A. Russo Lawrence R. Stanberry Britta Wahren David H. Persing R. Bradley Sack Ann E. Stapleton Mark A. Wainberg James J. Pestka Pekka Saikku Jack T. Stapleton Anna Wald Lance R. Peterson Mansour Samadpour Allen C. Steere Bruce D. Walker Phillip K. Peterson Mathuram Santosham Richard Stenberg Chris Walker Hans-Walter Pfister Heikki Sarvas Richard S. Stephens David H. Walker Sadhana S. Sathe Dennis Stevens John P. Phair L. M. Wallace David T. Scadden E. Richard Stiehm Mark R. Philips Christine Wanke Julius Schachter Gregory Storch Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Larry K. Pickering Joel 1. Ward Timothy Schacker C. Kendall Stover Gerald Pier Richard L. Ward Anthony Schaeffer Stephen E. Straus Nathaniel F. Pierce David A. Warrell Peter Schantz G. Thomas Strickland Philip A. Pizzo H. Shaw Warren Susan Plaeger David W. Scheifele James Stringer Ronald G. Washburn Richard Platt Mark Schiffman Terrence L. Stull D. Heather Watts Stanley A. Plotkin Raymond F. Schinazi John Z. Sullivan-Bolyai Scott Weaver Timothy H. Pohlman Theresa A. Schlager Jesse Summers Gary J. Weil Richard B. Pollard Mark Schleiss James T. Summersgill Howard L. Weiner Bruce Polsky Patrick Schlievert Paula Sundstrom Kent 1. Weinhold Steven Polyak Allan Schmaljohn Catharina Svanborg Robert A. Weinstein F. Maxine Preston Connie S. Schmaljohn Caroline M. A. Swanink Jerrold P. Weiss Richard W. Price Markus Schneemann Ronald Swanstrom Marc E. Weksler Alfred M. Prince Steven M. Schnittman Richard L. Sweet Peter F. Weller Alice Prince Gerald Schochetman Carol O. Tacket Raymond M. Welsh Gregory A. Prince Robert T. Schooley Francis Tally Jay D. Wenger David Proud Hanneke Schuitemaker Glen Tamura Thomas C. Quinn Tom G. Schwan Herbert B. Tanowitz Gail W. Wertz Richard Race Ira Schwartz Martin G. Tauber Michael Wessels James 1. Rahal Phillip A. Scott Robert V. Tauxe Nicholas 1. White Aquilur Rahman Leonard B. Seeff Nancy S. Taylor Richard 1. Whitley Silvia Ratto K. R. Seshan Amalio Telenti James Lindsay Whitton John L. Sever Sam R. Telford III Robert L. Rausch Judith A. Whittum-Hudson John A. Shadduck Elaine Thomas C. George Ray Peter M. Wiest Robert W. Shafer S. 1. Tilden Mohan M. Reddy Catherine M. Wilfert Eugene D. Shapiro Richard G. Titus Sharon L. Reed Richard A. Willson Gene M. Shearer Patricia A. Totten Steven G. Reed Kenneth H. Wilson Geoffrey R. Shellam Edmund C. Tramont William C. Reeves Robert K. Winn Steve Shiboski John Treanor Patricia S. Reichelderfer Marcia K. Wolf James W. Shih Christian Trepo Richard C. Reichman Jerry S. Wolinsky David M. Shlaes Birger Trollfors Neil Reiner Edward S. Wong Stanford T. Shulman Trevor J. Trust Steven L. Reiner Kimberly A. Workowski L. David Sibley Sergei A. Tsarev David Relman Gary P. Wonnser Robert W. Sidwell Joseph Tully Peter F. Wright Jack S. Remington Leonard H. Sigal Elaine Tuomanen Teresa L. Wright Heinz Remold John Sinclair Stephen K. Tyring David 1. Wyler Francois Renaud J. G. Patrick Sissons Matti Uhari Margaret B. Rennels John W. Sixbey Thomas R. Unnasch Koichi Yamanishi Louis B. Rice Paul R. Skolnik Fred T. Valentine Douglas B. Young Douglas D. Richman David P. Skoner Loek van Alphen MimiYu Stan Riddell Peter M. Small A. P. van Dam Victor L. Yu Charles R. Rinaldo, Jr. Arnold L. Smith Nicole C. van de Kar John A. Zaia Yves Riviere Thomas F. Smith Guido van der Groen Jonathan M. Zenilman John B. Robbins David R. Snydman Sander 1. H. van Deventer Marcus Zervos Michael N. Robertson Frederick S. Southwick Tom van Gool Elizabeth 1. Ziegler Hugh Robson Inara E. Souza Jos P. M. van Putten H. Kirk Ziegler L. Rodrigues David Spach A. 1. A. M. Vanderven Wendell D. Zollinger JID 1996; 173 (June) Author Index 1535

Carr, A., 321 Cohen, O. J., 849 Dhumeaux, D., 511 Falasca, L., 1367 Carreno, Y., 300 Cohn, J., 849 Dias, F., 245, 263 Fallon, P. G., 1460 Carriere, D., 565 Cohn, S., 579 Dickover, R. E., 1001 Falloon, J., 840 Carroll, K., 656 Coleman, R., 273 Diedrich, D. L., 226 Farhat, C. K., 1077 Carson, D. A., 822 Colina, K. F., 180 Diehl, Y., 1038 Farley, M. M., 365 Carson, L. A., 656 Colmenero, M., 509 Diller, L., 256 Farrell, 1. P., 979 Carter, C. 1., 403 Conant, M., 248 Dillner, 1., 1394 Farzadegan, H., 468 Cartter, M. L., 480 Connor, 1. D., 18 Dillon, M., 1001 Fasano, A., 1019 Carvalho, E. M., 269, 1515 Connors, M., 829 Di Luca, D., 542 Fast, P. E., 330 Casadevall, A., 1222 Coolbaugh, R., 1273 Dini, L., 1367 Fatkenheuer, G., 1038 Casas-Ciria, J., 1519 Cooper, D. A.. 321, 1092, 1354 Doe, R., 877 Fattorini, L., 1030 Cassai, E., 542 Cooper, J. A. D., Jr., 279 Doenhoff, M. J., 1460 Fauci, A. S., 60, 849 Cassone, A., 684 Cosma, A., 472 Dolan, M. J., 877 Feinberg, M., 476 Castro, A., 509 Costa, C. H., 1515 Dolcetti, R., 542 Feinstone, S. M., 24 Cater, 1., 550 Couch, R., 453 Dolin, R., 330, 340 Feldman, J., 77 Catrenich, C. E., 1288 Cox, N., 453 Donnell, H. D., 1527 Feldmesser, M., 1222 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Cattaneo, L. A., 1256 Coyle, B. S., 1260 Donnelly, J. J., 314 Feller, M., 1171 Cave, M. D., 934 Cranston, B., 718 Donsky, C., 1415 Fennis, J. F. M., 460 Cays, M., 1208 Craven, R. B., 1528 Doroshenko, E., 453 Fernandez-Munoz, R., 32 Cellini, L., 1288 Cravioto, A., 1019 Dreitz, M., 187 Ferreira, S. T. M. F., 1232 Celma, M. L., 32 Cross, A. S., 1157, 1415, 1422 Drew, W. L., 987 Ferretti, J. 1., 901 Cepparulo, M., 1367 Cross, 1., 440 Drinevsky, Y., 453 Ferriero, D. M., 166 Chacko, T. M., 1252 Crowe, J. E, Jr., 829 Drusano, G. L., 464, 1524 Fessel, J., 265 Chaisson, R. E., 219, 505, 857 Culbreth, R., 279 Duerr, A., 77 Fichtl, R. E., 1041 Chambers, G. W., 285 Cummings, P. K., 957, 1519 Dumler, J. S., 1027 Fidel, P. L., Jr., 425 Champe, M., 52 Cunha, S., 758 Duncan, B., 997 Field, H. J., 291 Chan, C. Y., 256 Cunningham, A. L., 7 Duncan,1. B., 1379 Fikrig, S., 1097 Chang, A., 619 Cutright, J. L., 425 DuPont, H. L., 232 Filgueiras, T. E., 1077 Chang, H. J., 656 Daidone, B. J., 77 Eastman, D. 1., 52 Fink, L. M., 60 Chanock, R. M., 829 Dallabetta, G. A., 714 Eaton, K. A., 1288 Firestone, C.-Y., 829 Chao, C. C., 1194 Daly, J. A., 656 Eberhard, T., 1137 Fish, D., 187 Chapman, L. E, 1297 Danforth, 1. M., 159 Echeverria, P., 440, 1019 Fleer, A., 212 Chappell, C. L., 232 Daniel, R. W., 714 Edwards, K. M., 1256 Fletcher, T. W., 934 Chariyalertsak, S., 1490 Dankert, 1., 1171 Edwards, M. S., 142 Flores, B. M., 226 Chaussee, M. S., 901 Darouiche, R., 418 Egan, A. F., 765 Fontaine, C., 565 Cheang, M., 950, 1437 Davey, R. T., Jr., 840 Ehrlich, G. D., 1072 Forde, A. S., 1092 Chen, C.-M., 457 Davey, Y., 840 Eickhoff, C. S., 285 Forrest, B. D., 330 Chen, C.-Y., 394 David, J. R., 758 Eisenach, K. D., 934 Fortier, M., 794 Chen, M., 24 Davidson, F., 727 Elkins, M. M., 1097 Fortney, K., 394 Chen, S. C. A., 754 Davison, D., 52 Elkins, W. R., 829 Fowler, M. G., 1097 Chen, T.-Z., 457 Daynes, R. A., 536 Elliot, J., 365 Fox, C. H., 849, 1485 Chene, G., 91 Deal, C. D., 1422 Elliott, B. R., 1216 Francis, D. P., 52 Cheng, Y.-C., 1252 de Almeida, A. B., 1453 Ellis, D. H., 754 Francot, G. J. M., 252 Cherrington, J. M., 987 Decker, C. F., 1107 Ellis, R. W., 314 Frankel, R., 957 Chiba, S., 503 De Clercq, E., 18 Ellner,1. J., 410 Franzen, C., 1038 Chiphangwi.T, D., 714 Deelder, A. M., 1232, 1242 Emerson, S. U., 592 Freedman, D.O., 1453 Choi, Y., 1263 de Goede, R. E Y., 349 Emerson, T., 619 Freeman, J., 787 Choo, K.-B., 457 de Groot, R., 1148, 1498 Engelhard, D., 735 Freeman, W. R., 18, 1481 Chou, S., 523 de la Durantaye, R., 1034 Enscore, R. E, 781 Freire, M., 758 Chou, T-C., 355 Delahunty, T, 273 Erban, J., 1164 Frey, C. L., 203 Christen, A., 794 Delanay, K., 1034 Erice, A., 523 Frey, S. E., 330 Christenson, J. C., 656 Delaney, S. F., 1092 Erwin, M., 365 Friedland, G., 1252 Christner, R. B., 104 de Lellis, L., 542 Escobedo, D., 1267 Fn,;land, S. S., 259 Chuck, S., 248 Delgado, K. L., 1273 Escoffery, c, 718 Frosch, M., 172 Chung, R. C. Y., 1523 DeMarsh, P. L., 203 Eskola, J., 136 Frye, B., 1072 Chyou, P.-H., 1474 de Moraes-Pinto, M. 1., 1077 Espevik, T, 259 Fujihashi, K., 627 Clarke, L. M., 77 de Nijs, R., 460 Espinal, M. A., 488 Fung, 1. J., 1072 Clements, J. D., 627 Dennis, D. T, 1528 Ettestad, P., 781 Gajadhar, A., 440 Clements, M. L., 44, 340 Dentener, M. A., 252 Eulalio, M. C., 758 Ga1ama, J. M. D., 460 Clerici, M., 472, 1085 Deresinski, S. c, 677, 750 Evans, L. A., 1092 Galetto-Lacour, A., 1388 Cloud, G. A., 499 De Santis, C., 472 Evans, T J., 1399 Galgiani, 1. N., 499, 1273 Cobb, E. K., 52 Detels, R., 1477 Facchin, M., 684 Gallant, J. E., 219, 505 Coffman, R. L., 1515 Detmer, 1., 727 Facklam, R. R., 365, 374 Ganem, D., 248 Cohen, J., 870, 1399 Dewar, R., 840 Faggioli, E., 1367 Garcia-Samaniego, 1., 509 1536 Author Index JID 1996; 173 (June)

Garner, R. B., 1252 Gunn, R. A., 1263 Hoffner, S., 263 Jordan, M., 1292 Garratty, E., 1001 Gupta, R. K., 1493 Hofheinz, D., 1523 Jordan, M. c, 523, 1304 Gary, H., 453 Guttormsen, H.-K., 142 Hegdsen, K., 647 Joyce, W., 743 Gary, H. E., Jr., 787, 1470 Haase, D. H., 1256 Hohmann, E. L., 1408 Jungi, T. W., 971 Gavrilov, A., 453 Hachem, R., 418, 495 Holder, A. A., 765 Kagan, J., 1336 Gaydos, C. A., 957 Hackett, C. S., 1467 Hollingshead, S. K., 896 Kager, P. A., 1506 Gazit, A., 927 Hackett, S. P., 619 Holloway, B. P., 1284 Kalbacher, H., 1051 Gebo, K. A., 857 Hafner, R., 91 Holman, R. C., 1297 Kiillenius, G., 263 Gekker, G., 1194 Hagan, J. B., 1277 Holodniy, M., 849 Kallings, I., 1394 Gelber, R., 1097 Hiihlen, K., 1498 Honkanen, P.O., 387 Kapur, V., 196 Gelderman, M. P., 1202 Ham, D. J., 1062 Hood, A. F., 394 Karma, P., 136 George, S., 256 Hamada, S., 627, 1428 Hoover, D. R., 468, 504, 1477 Karron, R. A., 44 Gerrits, Y., 1171 Hamilton, B., 410 Hop, W. C. J., 1148 Kartalija, M., 1216 Gershon, A. A., 450 Hamilton, 1. R., 677, 750 Hopkins, D. P., 1263 Kaslow, D. C., 765 Ghibelli, L., 1367 Hamilton, R. G., 83 Houghton, R. L., 758 Kasper, D. L., 142 Giacobbe, K. D., 98 Hamlin, D. M., 787 Howard, R., 1273 Katongole-Mbidde, E., 248 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Giebink, G. S., 119 Hammack, C., 1157 Hsieh, R.-H., 330 Katzenstein, D., 1336 Gillitzer, R., 699 Hammerschlag, M. R., 957 Hsu, H. W., 870 Katzenstein, D. A., 1005 Giugni, T. D., 1062 Hammerschmidt, S., 172 Hu, S., 1194 Kawano, Y., 1115 Glass, R. I., 787 Hanchard, B., 718 Hubbard, B. S., 722 Kaye, K., 1216 Gleich, G. J., 1277 Hanggi, M., 1379 Hughes, J., 1320 Kayhty, H., 136 Glesby, M. J., 1477 Hanson, C. V., 330 Huguet, M.-F., 565 Kebede, S., 1470 Glover, c., 1009 Harb, G. E., 273 Humphrey, C. D., 787 Keefer, M. C., 330, 340 Goddard, E. A., 1320 Harima, Y., 997 Hurren, L., 1092 Keitel, W., 453 Gonzalez, 1., 509 Hariprashad, J., 1041 Hussey, G. D., 1320 Kelleher, A. D., 321 Gonzalez-Lahoz, J., 509 Harmsen, W. S., 446 Hutton, N., 1097 Kemper, C. A., 677, 750 Gooley, T., 1208 Harper, M., 870 Huycke, M. M., 743 Kendal, A., 453 Goorin, A., 256 Harrer, E., 476 Ieven, M., 1445 Kenj, G., 1077 Goossens, H., 1445 Harrer, T., 476 Ilstrup, D. M., 446 Kerran, M., 1320 Gopinath, R., 1510 Harrigan, P. R., 1354 International HCV Collaborative Keruly, J. c, 219, 857 Gorse, G. J., 285, 330, 340 Harrison, C. J., 1 Study Group, 727 Kessler, H., 1085 Govindarajan, S., 592 Hart, C. A., 1077 Ison, C. A., 172 Kesson, A. M., 7 Graber, J., 1297 Hashemi, F., 1085 Israel, E., 1260 Ketter, N., 330 Graham, B. S., 340 Haslett, P. A. 1., 1336 Ivakhov, I., 453 Ketterer, M., 636 Graham, N. M. H., 504, 1477 Hatano, N., 1115 Jabs, W. J., 1248 Keusch, G. T., 1164 Graninger, W., 1281 Haubrich, R. H., 942 Jacewicz, M. S., 1164 Khabbaz, R. F., 1297 Grant, R. M., 248 Haug, C. J., 259 Jackson, L. A., 1023 Khan, A. S., 453, 1297 Grayston, J. T., 1519 Havlir, D. V., 942 Jackson, R. J., 627 Khoshnood, K., 997 Graziosi, C., 849 Hawkes, C. A., 1523 Jacobs, R. A., 1292 Kierulf, P., 647 Green, J. H., 480 Hawley, W. A., 1284 Jacobsen, H., 1379 Kilgore, P. E., 787 Green, M. D., 1506 Hayashi, K., 1115 Jacobson, M. A., 273 Killeen, K. P., 1408 Greenberger, M. J., 159 Hazelzet, J. A., 1148 Jacobus, D. P., 1044 Kim, G., 1252 Greenspan, D., 710 Heath, 1. L., 1470, 32 Jaffar, S., 245 Kim, Y. S., 166 Greenspan, J. S., 710 Hedlund, K.-O., 1062 Jahn, G., 240 Kimani, J., 950, 1437 Greenwood, B. M., 765 Heimer, R., 997 Jain, R. C., 669 Kindt, T. J., 722 Grefte, A., 240 Helfand, R. F., 1470 Janigan, D., 484 King, G. E., 32 Gregory, T. J., 52 Hellewell, P. G., 1460 Janoff, E. N., 778 King, 1. c., 1313 Griffin, D. E., 1320 Hellyer, T. J., 934 Jansen, A., 565 Kinghorn, I., 1354 Griffin, P., Jr., 1493 Hendricks, K. A., 1263 Jansen, K. D., 314 Kioski, c., 781 Griffin, P. M., 1263 Henning, K. J., 1263 Jariwala-Freeman, B., 997 Kippen, D. A., 1023 Griffith, B. P., 1252 Hepatitis-HIV Spanish Study Jarvis, W. R., 656, 1293 Kira, J., 1115 Groeschel, M. c., 739 Group, 509 Jay, M., 781 Kirchner, H., 1248 Grogan, 1. L., 1242 Hertz, M. I., 1304 Jayaraman, K., 769 Kita, H., 1277 Groover, J. E., 1347 Herva, E., 387 Jenkins, E., 656 Kiyono, H., 627, 1428 Gros, P., 565 Heyderman, R. S., 172 Jero, J., 136 Klein, N. J., 172 Grossi, P., 1072 Hinshaw, L., 619 Jew, L., 550 Klontz, K. c, 1176 Gruber, W. c., 1313 Hirsch, M. S., 355 Jhung, J. W., 1415 Kludt, P. E., 787 Grumet, F. C., 265 Hirschel, B., 1294, 1388 Jimenez, E., 1097 Kliiter, H., 1248 Gryseels, B., 1232 Hitchcock, M. J. M., 987 Jin, L., 32 Kluytmans, J. A. J. W., 914 Guderian, R. H., 773 Hjelle, B., 781 Jobe, 0., 245 Kobayashi, T., 1115 Guerreiro, J., 1515 Hlady, W. G., 1176 Johnson, J. R., 746, 920 Koelle, D. M., 491 Guglielmo, B. J., 1292 Hlavacova, B., 374 Johnson, P. M., 1077 Koff, W. C., 330 Gulick, L., 68 Ho, M., 1477 Johnson, R. P., 476 Kohler, H., 512 Gump, D. W., 1347 Ho, M. K.-L., 1009 Johnson, W. D., 1515 Koivula, T., 263 JID 1996; 173 (June) Author Index 1537

Kolberg, J., 727 laSala, A., 1030 Mahanty, S., 769 Merrill, D. P., 355 Kolls, 1. K., 432 Laskay, T., 699 Maia e Silva, M. C, 1453 Mervish, N., 450 Konstan, M. W., 514 Latief, Z., 1320 Maitha, G. M., 950, 1437 Merz, W. G., 219 Koot, M., 349 Laue, N. W., 909 Makhene, M. K., 44 Metcalf, J. A., 840 Kootstra, N. A., 349 Laufer, D. S., 731 Makin, K. M., 1288 Metzger, W., 1242 Kopp, 1. B., 1485 Lavandera, M., 488 Malone, J. L., 1107, 1523 Meyaard, L., 460 Koppen, S., 265 Lavelle, J., 1354 Mamelok, R. D., 1208 Michie, C. A., 274 Korhonen, T. K., 1137 Lavoie, M. C., 1034 Mandema, J. W., 273 Miedema, F., 460 Korne1isse, R. F., 1148, 1498 Law, M. G., 1092 Manez, R., 1072 Mik1oska, Z., 7 Korten, V., 1129 Le, C. T., 119 Mani, c., 1 Miller, G., 1297 Korvick, J., 1336 Leclercq, R., 1129 Manns, A., 718 Miller, S. 1., 1408 Kosanke, S., 619 Lee, A. Y., 1009 Mansouri, M., 418 Milligan, P. J. M., 1077 Koskela, P., 1394 Lee, F. K. N., 636 Mao, c, 870 Miner, R., 987 Koster, F. T., 781 Lee, S.-D., 457 Mapou, R. L., 1107 Mink, C. M., 1014 Kotb, M., 274 Lefkowitz, D. L., 1202 Maras, B., 684 Miotti, P. G., 714 Kotylo, P., 394 Lefkowitz, L., 1354 Marcotte, H., 1034 Miralles, G. D., 60 Kovacs, J. A., 840 Lefkowitz, S. S., 1202 Mardh, P. A., 1394 Mira, J., 91 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Kowalski, R., 68 Lehtinen, M., 1394 Margolick, 1. B., 468 Mitchell, C. D., 1097 Koyanagi, Y., 1115 Leib, S. L., 166 Marinaro, M., 627 Mitchell, L. A., 1009 Kozlow, E., 877 Leinonen, M., 128, 136,387 Markowitz, L. E., 1320 Modansky, M., 365 Krajcfkova, L., 374 Lennette, E. T., 710 Marrie, T. 1., 484 Modern, P. A., 98 Krakowka, S., 1288 Leno, M., 722 Marthas, M. L., 1327 Mogui1evsky, N., 1202 Krasinski, K., 574 Leport, C., 91 Martin, J., 300 Molina, 1., 1019 Krausz, T., 1399 Lesser, M. L., 68 Martinez, D., 314 Molitor, T. W., 1194 Krawczynski, K., 822 Levesque, D., 1034 Mas, A., 509 Moll, H., 699 Kreiswirth, B. N., 196 Levin, M., 172 Masaki, T., 24 Moller, E., 1062 Kremsner, P. G., 1242 Levine, M. M., 1019 Mascola, J. R., 340 Mollis, S. N., 769 Kriesel, 1. D., 536 Levine, O. S., 579 Masso, F., 1047 Mollnes, T. E., 647 Kringstad, B., 1304 Levine, W. c. 1263 Masters, E. J., 1527 Molrine, D. c, 256 Krishna, S., 691 Levitzki, A., 927 Masur, H., 840 Monroe, S. S., 787 Ksiazek, T. G., 1297 Levy, R., 1502 Mattei, M., 1030 Montano, L. F., 1047 Kubofcik, J., 773 Lew, D., 800 Matthews, T., 52 Montecalvo, M., 1293 Kumaraswami, V., 769 Lewandowski, T. F., 203 Matthews, T. J., 330 Montefiori, D. C., 60 Kundu, S., 1336 Lewis, M. L., 499 Mattsson, E., 212 Montgomery, D. L., 314 Kundu, S. K., 1005 Liang, Y. Y., 1260 Mauch, P., 256 Montoya, J. G., 265 Kunkel, S. L., 159 Liao, M.-1., 1107 Maupin, G. 0., 403 Moodie, J., 1320 Kuo, c.c. 1519 Liebe1er, C. L., 119 Mayers, D. L., 1523 Moonis, M., 355 Kuo, G., 822 Lien, E., 259 Mayur, R., 472 Moore, M., 1354 Kuppermann, B. D., 18 Linderho1m, M., 38 McCarter, R., 1260 Moore, R. D., 219, 237, 505, Kuppers, R., 1038 Lindquist, E. A., 609 McCarthy, J. S., 1510 857 Kusne, S., 1072 Liomba, G. N., 714 McChesney, M. B., 1327 Moran, E. E., 1157 Kuter, B. 1., 731 Liu, J., 901 McCutchan, F. E., 340 Mordmuller, B., 1242 Kuuse1a, P., 1137 Liu, M. A., 314 McCutchan, J. A., 942 Morin, C., 794 Kyle, D. E., 691, 1506 Liu, Q., 1216 McDaniel, L. S., 380 Morlat, P., 91 Lacerda, L., 263 Livingston, D. J., 1525 McElrath, M. J., 340 Morris, J., 765 Lacke, C. E., 1347 Lo, S. H., 450 McGhee, J. R., 627, 1428 Mosley, D. G., 781 Lafeuillade, A., 1522 Lobel, H. 0., 1506 McGillicuddy, D. c., 159 Mostowski, H., 863 Lahart, C. J., 1347 Lonskaya, N. L., 453 McGrath, N., 1097 Mous, J., 1379 Lahteenmaki, K., 1137 Looareesuwan, S., 1281 McIntosh, K., 870, 1097 Mouton, J. W., 914 Laicha1k, L. L., 159 Lottenbach, K., 1014 McKinnis, R., 1354 Moyes, D., 1399 La1, A. A., 1284 Lu, M.-L., 574 McMahon, D., 849 Mshar, P., 480 La1ezari, J., 849 Luber, A. D., 1292 McNeil, 1. G., 340 Mueller, B. D., 1485 La1ezari, 1. P., 987 Luft, B. J., 91 McQueen, P. W., 1092 Mueller, N. E., 584 Lambert, S., 822 Lukehart, S. A., 491 McSherry, G., 1097 Mukherjee, S., 1222 Lambert-Fair, M. A., 480 Lundeberg, J., 992 McVeigh, A., 1019 Mulder, J. W., 1354 Lamme1, C. J., 609 Lundergan, L. L., 1273 Meeks, E., 822 Mulder, P. H. G., 1498 Landay, A. L., 1085 MacDonald, K., 1437 Mehra, N. K., 669 Muller, A., 1038 Landesman, S. H., 77 Mach, M., 1051 Meier, J. D., 119 Muller, F., 259 Landmann, R., 661 Maciel, M. A., 1453 Meier, P., 450 Muller, S., 512 Lane, H. C., 840 Mack, M. E., 306 Meisels, A., 794 Mundy, L. M., 237 Lane, J. R., 1523 Maclean, 1. W., 950, 1437 Melcher, G. P., 877 Munguia, D., 18 Lange, J. M. A., 1354 Madureira, C., 758 Mellors, J. W., 1252 Murphy, B. R., 44, 829 Larder, B. A., 1354 Maenza, J. R., 219 Meltzer, M. S., 1107 Murphy, D., 863 LaRussa, P., 450 Magnano, A. R., 480 Merigan, T. C., 1005, 1336 Murray, B. E., 1129 1538 Author Index JID 1996; 173 (June)

Murray, H. W., 762, 1041 Oliveira, D. A., 1284 Pfeiffer, T., 754 Reich1er, M. R., 374 Murthy, K. K., 52 0100, A. J., 1284 Phair, J. P., 1477 Reingold, A. L., 488 Musher, D. M., 83, 1347 Olson, C. A., 1304 Phillips, N. R., 256 Reis, N., 1273 Musser, J. M., 128, 196 Opal, S. M., 1157, 1415 Piedra, P. A., 1313 Relman, D. A., 440 Myers, M. G., 1 Orazi, A., 394 Pier, G. B., 513 Remington, J. S., 265 Myneedu, V. P., 669 Orefici, G., 1030 Piesman, J., 403 Rennels, M. B., 306 Nabors, G. S., 979 Orenstein, J. M., 849 Piette, J., 1045 Reynes, J., 565 Nage1kerke, N. 1. D., 950, 1437 Ostovic, E. J. R., 203 Pipitapom, B., 691 Reynolds, P., 781 Nah1en, B. L., 1284 O'Toole, C., 512 Piscitelli, S. C., 840 Ricard, D., 245 Nahm, M. H., 113 Otsyu1a, M. G., 1327 Pizzo, P. A., 1485 Rice, L. B., 151 Nakagawa, 1., 627, 1428 Ott, M., 1379 P1achter, B., 240 Rice, P. A., 636 Nakamura, G. R., 52 Otten, M. F., 739 Placido, R., 1367 Rich, E. A., 1046, 1267 Nakamura, M., 1115 Ottesen, E. A., 769, 1277, 1510 Platt, R., 963 Riesenberg, K., 1502 Nakamura, T., 1115 Otto, E. E., 285 Plummer, F. A., 491, 950, 1437 Rigaud, M., 574 Nakazawa, T., 24 Owen, S., 1379 Poggi, C., 1522 Riley, E. M., 765 Napolitano, B., 68 Oyugi, 1., 1437 Polak, J., 1399 Rinaldo, C., 1072 Nara, P., 512 Padian, N. S., 1521 Po1ezhaev, F., 453 Risseeuw-Appe1, I. M., 1148 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Nasio, J. M., 491 Paez, A., 1047 Polis, M. A., 840 Ritter, D., 699 Naso, R., 1157 Pahwa, S., 68 Pollack, H., 574 Rivera, R., 1493 National Institute of Allergy and Palardy, J. E., 1415 Pomerantz, R. J., 550 Robbioni, P., 472 Infectious Diseases Mycoses Pa1efsky, 1. M., 710, 718 Porath, A., 1502 Robertson, B. H., 822 Study Group, 499 Pande, J. N., 669 Portela, D. F., 446 Robinson, N. 1., 1526 Naucler, A., 245, 263 Pandey, 1. P., 1347 Porter, D. D., 598 Roblin, P. M., 957 Navas, S., 300 Pantaleo, G., 60, 849 Portmore, A., 265 Rocchi, G., 1367 Neice, C. M., 1460 Paoletti, L. C., 142 Powell, M. F., 52 Rochford, G., 574 Neijens, H. J., 1498 Papaevange1ou, V., 574 Powers, D. C., 285, 1014, 1467 Rodriguez-Barradas, M. C., 83, Nelson, K. E., 83, 579, 1490 Pappagianis, D., 499 Prince, A. M., 808 1347 Netto, E. M., 758 Pardo, M., 300 Prince, G. A., 598 Rodriguez-Iglesias, M. A., 1519 Neustock, P., 1248 Parejo, N. A., 1415 Proctor, R. A., 739 Rollin, P. E., 1297 Newman, F., 1313 Park, L. P., 504 Profizi, N., 1522 Rollof, J., 212 Newman, F. K., 285 Parredes, W. Y., 773 Pueyo, S., 91 Roman, S., 950 Newman, M., 24 Parsonnet, 1., 98 Pugh, E., 1273 Rooney, J. F., 1354 Ngom, P. T., 245 Parta1edis, 1. A., 1525 Pukrittayakamee, S., 691 Roorda, P., 1171 Niang, M., 1232 Patel, R., 446 Purcell, R. H., 592 Roos, M. T. L., 460 Nichol, S. T., 1297 Patton, D. L., 957, 1519 Pursley, M., 18 Rosales, F. J., 507 Nielsen, K., 1001 Patya, M., 927 Quartey, M. K., 119 Rosenthal, D. S., 787 Nieminen, T., 136 Pau, B., 565 Quinn, T. C., 957 Ross, A. c, 507 Niesters, H. G. M., 1445 Paul, M. 0., 68 Quint, W., 1445 Rossi, C. A., 237 Nimmo, G., 754 Pavia, A. T., 656 Quirinale, J., 472 Rota, J. S., 32 Nishioka, M., 24 Pav1akis, G. N., 849 Quirk, M. R., 523, 1304 Rota, P. A., 32 Niu, M., 849 Paw1otsky, J.-M., 511 Quiroga, J. A., 300 Rotmans, J. P., 1232 Nizet, V., 180 Paya, C. V., 446 Raad, t., 418, 495 Rouse, M. S., 909 Noah, T. L., 1050 Pazhanisamy, S., 1525 Raeder, R., 888 Rousseau, F., 91 Noel, J. S., 787 Peakman, M., 172 Rager, 1. R., 1263 Roy, M., 794 Nomura, A., 1474 Pearce, E. J., 269 Raja1ingam, R., 669 Rubens, C. E., 180 Norberg, R., 263 Pediatric AIDS Clinical Trials Rakovsky, J., 374 Rubinstein, A., 1097 Novak, R., 849 Group, 1097 Ralph, B. A., 380 Ruf, B., 265 Novogrodsky, A., 927 Pediatric Care Center, 44 Ramachandran, R., 1005 Ruiz, N. M., 1523 Numazaki, K., 503 Pedra1-Sampaio, D., 758 Ramirez, T., 1047 Ruiz, V., 1047 Nutman, T. B., 769, 773, 1277, Peeling, R. W., 1437 Ramirez-Ronda, C., 1354 Ruma, P., 754 1510 Peer, G., 619 Ramisse, F., 1123 Rumpold, H., 1281 Obijeski, 1. F., 52 Pefia, c, 1260 Raoult, D., 484 Ryan, I., 550 O'Brien, E., 1519 Penaranda, M.-E., 710 Rappocciolo, G., 472 Ryon, J. 1., 1320 O'Brien, T. R., 1521 Penfold, M. E. T., 7 Rattray, c, 718 Saah, A. 1., 468, 504, 1477 Ochnio, 1. J., 1009 Peng, T., 499, 1273 Ravichandran, M., 769 Sabin, E. A., 269 Odeberg, J., 992 Penney, K., 957 Razzouk, B. I., 529 Sada, E., 1267 O'Farrell, N., 1520 Pennington, K. N., 1354 Readdy, T. L., 896 Sadoff, J. C., 1157, 1422 Ohrt, C., 1506 Pensart, N., 1129 Reber, A. M., 661 SadZiene, A., 1184 Okayama, A., 584 Pemeger, T. V., 1388 Reddington, C., 870 St. Clair, M., 1354 Okhuysen, P. C., 232 Perrin, L., 1388 Reed, G. W., 1256, 1313 St. George, K., 1072 Olander, J. V., 113 Peterhans, E., 971 Reed, S. G., 559, 758 Salamon, R., 91 01ariu, R., 432 Peters, C. J., 1297 Reef, S., 1297 Sa1anitro, A., 1367 01dach, D., 237 Peterson, P. K., 1194 Regnery, H., 453 Sa1hi, S. L., 565 Oletta, C. A., 1408 Peveri, P., 971 Regnery, R. L., 1023 Salmon, L. E., 1047 JID 1996; 173 (June) Author Index 1539

Salmon-Ceron, D., 1045 Sierra, M. F., 77 Strebel, P. M., 1320 Torriani, F. J., 942 Salzberger, B., 1038 Sikstrom, B., 1394 Strickland, G. T., 1260 Tosi, M. F., 514 Salzman, N. P., 840 Simmonds, P., 727 Strickler, H. D., 718 Treanor, J. J., 1313, 1467 Sample, C. E., 529 Simonetti, N., 684 Strieter, R. M., 159 Trembovler, V., 735 Sande, M. A., 1216 Simpson, R. M., 722 Strine, T., 1297 Tsarev, S. A., 592 Sands, K., 963 Singh, V., 529 Stringaro, A., 684 Tung, R. D., 1525 Sands, L., 781 Sinha, S., 822 Stuver, S. 0., 584 Tureen, 1. H., 1216 Sankilampi, U., 387 Sinzger, C., 240 Stuyver, L., 511 Tytgat, G. N. J., 1171 Sansano, S., 661 Sirisanthana, T., 1490 Subbarao, K., 44 Udomsangpetch, R., 691 Santos, A. M. N., 1077 Sison, 1. P., 677, 750 Sugg, N. K., 1023 Uhlen, M., 992 Sapp, M., 1394 Sixbey, J. W., 529 Sukhai, R. N., 1498 Ullberg, M., 1137 Sappey, C., 1045 Skillman, D. R., 1107, 1422 Sundar, S., 762 Urbani, F., 1030 Sarisky, J., 781 Skumick.T. H., 1521 Supparatpinyo, K., 1490 Urdea, M., 727 Savarino, S. J., 1019 Slacikova, M., 374 Suputtamongkol, Y., 691 Ursi, D., 1445 Savelkoul, H. F. J., 1148, 1498 Smith, A. L., 180 Suur, M. H., 1148, 1498 Vahey, M. T, 877, 1523 Sayed, R., 1320 Smith, D. B., 727 Suzuki, 1., 1115 Valentine, F. T., 1336 Sayers, M. H., 1023 Smith, G. E., 1336, 1467 Suzuki, Y., 265 van Alphen, L., 1137 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Schachter, 1., 957 Smith, 1. L., 1481 Svenson, S., 263 van Ameijden, E. 1. C., 1506 Schiffman, M. H., 718 Smith, T., 275 Swanink, C. M. A., 460 Van Bever, H., 1445 Schiller, J. T., 1394 Smith, T. F., 446 Swiatlo, E., 777 van Burik, J.-A., 1208 Schlaeffer, F., 1502 Snyder, S. W., 340 Swiss HIV Cohort Study Group, Vance, E., 237 Schlievert, P. M., 1290 Sobel, J. D., 425 1388 van Dam, G. J., 1232, 1242 Schmidt, K. A., 1422 Sobotova, A., 374 Szatanik, M., 1123 Van Delden, C., 1294 Schmidt, T M., 440 SOderberg, c, 1062 Tabor, E., 1474 Van der Auwera, P., 1129 Schneider, H., 1422 Sogin, M., 440 Tachibana, N., 584 van der Ende, A., 117l Schnittman, S., 849 Sominina, A., 453 Tait, L., 425 van der Heijden, A. J., 1498 Schonberger, L. B., 453 Sonnerborg, A., 992 Takahashi, 1., 1428, 627 van der Hulst, R. W. M., 1171 Schonthal, E., 1281 Soriano, V., 509 Takala, A. K., 128 van der Meer, 1. W. M., 460 Schooley, R. T., 1354 Sorrell, T. C., 754 Talla, 1., 1232 van der Straaten, P. J. C., 1498 Schrappe, M., 1038, 265 Sotir, C. M., 896 Tamalet, C., 1522 van der Ven-Jongekrijg, J., 460 Schriefer, M. E., 1528 Spach, D. H., 1023 Tankersley, D. L., 822 van der Voort, E., 1148 Schuchat, A., 365 Spector, S. A., 1481 Tappero, 1., 1297 Van Devanter, N. L., 1521 Schuitemaker, H., 349 Speed, B. R., 754 Tarara, R. P., 1327 Van De Verg, L., 1422 Schulhoff, N., 957 Spelbring, 1. E., 822 Tarbell, N. J., 256 Van Dijk, H., 212 Schumacher-Perdreau, F., 265 Spino, c, 1336 Tarina, P., 374 van Embden, 1. D. A., 196 Schwander, S. K., 1267 Spinola, S. M., 394 Tarkka, E., 128 van Gool, T, 1506 Schwartz, D. H., 340 Spruance, S. L., 536 Tarnvik, A., 38 Vanichkin, A., 927 Schwartzentruber, D. J., 1485 Srinivas, S., 529 Tart, R. c. 380 Van Kessel, K., 212 Sei, S., 1485 Sriskandan, S., 1399 Tauber, M. G., 1216, 166 Vann,1. M., 739 Semba, R. D., 509 Staehle, B., 731 Tauxe, R. V., 480 Vannaphan, S., 1281 Semenuk, M., 1157 Stamm, W. E., 1023 Tawadros, R., 550 Van Rompay, K. K. A., 1327 Sethabutr, 0., 440 Stanberry, L. R., 1,800 Taylor, R., 1157 van Soolingen, D., 196 Settergren, B., 38 Standiford, T. J., 159 Tedder, R. S., 245 van Thiel, P. P. A. M., 1506 Sewell, C. M., 781 Stanley, S. L., Jr., 226 Teichert, M., 1194 van 't Wout, A. B., 349 Shah, K. V., 714 Stead, W. W., 934 Teixeira, M. M., 1460 Van Voorhis, W. C; 491 Shamberger, R. c.. 256 Steckelberg, J. M., 909 Teltow, G. J., 403 Vasile, L. L., 480 Shani, J., 957 Steel, H., 1354 Templeton, G. L., 934 Vasiljeva, R., 453 Shapiro, M., 592 Steers, J. L., 446 Tendeloo, D. C. H., 1506 Vasquez, M., 1336 Shay, D. K., 1293 Steigbigel, R. T, 849 Tersmette, M., 349 Velazco, 0., 699 Shearer, G. M., 1085, 472 Stein, A., 484 Testa, D., 1107 Vella, S., 1379 Sheiner, L. B., 273 Stein, D. S., 464, 504 Tetali, S., 68 Veltink, R. L., 1506 Shellito, 1. E., 432 Steinberg, S., 450 Thackray, A. M., 291 Vendrell, J.-P., 565 Shen, c, 950 Steinhoff, M. C., 44, 83 The, T H., 240 Vennari, 1. C., 52 Shi, Y. P., 1284 Stellrecht, K., 464 Theis, J., 1273 Ventura, L., 1367 Shinkai, M., 1481 Stelma, F. F., 1232 Thompson, C., 1493 Venzon, D. 1., 1485 Shirabe, S., 1115 Stemmermann, G. N., 1474 Thompson, P. A., 1184 Verbrugh, H. A., 914 Shirai, M., 24 Stephens, D. S., 365 Tierno, P. M., Jr., 1289 Vercoulen.T, H. M. M., 460 Shiratsuchi, H., 410 Stephens, L. C., 495 Tjhie, J. H. T., 914 Verhoef, 1., 212 Shlaes, D. M., 151 Stephens, R. S., 609 Tobias, W., 1077 Verma, P., 656 Shohami, E., 735 Sterling, C. R., 232 Todd, G. D., 1506 Vesga, 0., 739 Shriker, 0., 1502 Stevens, D. A., 677, 750 Toossi, Z., 410 Vetten, B., 1038 Siber, G. R., 113, 1493 Stevens, D. L., 619, 901 Torian, B. E., 226 vnae, J.-L., 91, 1045 Siccardi, A. G., 472 Stewart, D., 1519 Torres, M., 1267 Villa, M. L., 472 Sierra, J. G., 1267 Stratton, C. W., 909 Torrez-Martinez, N., 781 Vineyard, G., 963 1540 Author Index JID 1996;173 (June)

Virko1a, R., 1137 Wei, L. S., 1001 Williams, D. L., 196 Yazdanbakhsh, M., 1242 Viro1ainen, A., 136 Weiland, 0., 992 Williams, S. A., 1510 Yen, F.-S., 457 V1ahov, D., 509, 579 Weinberg, E. D., 1045 Williams, T. J., 1460 Yerly, S., 1388 von Laer, D., 503 Weinberg, G. A., 1045 Wills, M. J., 1256 Yoder, K, 440 Voorhees, R. E., 781 Weinhold, K J., 330 Wilson, M. H., 44 Yogev, R., 1097 Vuong, C., 18 Weintrub, P. S., 1097 Wilson, W. R., 909 Yong, T.-S., 226 Vuopio-Varki1a, J., 128 Weis1ow, O. S., 340 Winqvist, N., 263 Young, L. D., 1157, 1415 Waage, A., 38 Weiss, S. H., 472 Winters, M. A., 1005 Yun, Z. B., 992 Wachter, H., 971 Weiss, S. M., 957 Wong, M. T., 877 Yzerman, E. P. F., 914 Wack, M. F., 743 Weiss, W., 276 Wong, S.-Y., 265 Zaia, J. A., 1062 Wafer, D., 1001 Wellcome Resistance Study Woods, M. L., 656 Zaki, S. R., 1297 Wagner, H. J., 1248 Collaborative Group, 1354 Wright, P. F., 1313,44 Zaunders, J., 321 Wagner, K F., 1107, 340 Wells, G. I., 203 Wrin, T., 52 Zeidner, N., 187 Wagner, 0., 1281 Weng, S., 1477 Wu, r.c, 457 Zermeno, A., 495 Walker, B. D., 476 Wenisch, c, 1281 Wyeth-Ayerst CA Influenza Zhao, Q., 609 Walker, M. C., 340 Wenisch, H., 1281 Vaccine Investigators Group, Zheng, N. N., 1092 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Walker, R. E., 840 Werner, E. R., 971 1313 Zhong, M., 1510 Wang, S.-P., 1519 White, C. J., 731 Wylie, H. J., 1422 Zhou, D., 636 Wang, X. P., 68 White, N. J., 691 Xiao, Y., 1030 Zhou, J. T., 60 Wang, Y.-F., 808 Whittle, H., 245 Xu, J., 1493 Zhou, J. Y., 60 Ward, R. L., 306 Wieden, M. A., 1273 Yamamoto, N., 1115 Zhou, S. Y. 1., 1523 Warner, M. L., 237 Wiesner, R. H., 446 Yamasaki, K., 1115 Zimmerli, W., 661 Warren, R. L., 1422 Wi1airatana, P., 1281 Yang, C., 950 Zito, E. T., 306 Watson, B. M., 731 Wiley, C. A., 18 Yang, L.-P., 714 Zollinger, W. D., 1157 Watson, J., 1019 Wilfert, C. M., 1097 Yang, W., 226 Zolopa, A. R., 265 Wee1,1. F. L., 1171 Wilkins, A., 245 Yao, Y., 677, 750 Wilkinson, B. E., 1467 Yap, P.-L., 727 1541

Subject Index S. pyogenes, necrotizing fasciitis, mouse, 1399 UTI, ascending, inoculation conditions, mouse, 746 Antibody HLA class I, in HIV-negative, high-risk IDUs, 472 1,25 dihydroxyvitamin D, in disseminated MAC infection, in AIDS, 259 neutralizing, against HIV-I, 340 ,B-Iactam-,B-Iactamase inhibitor combinations, K. pneumoniae passive, for neonatal HSV infection, I resistance, 151 Antibody to Acyclovir C. immitis, serologic diagnosis, 499 for HIV infection, survival in, 504, 505 Coccidioides, detection, for diagnosis, 1273 for neonatal HSV infection, I E. coli enterotoxin, mouse model, 1428 risk for Kaposi's sarcoma, Multicenter AIDS Cohort study, 1477 H. infiuenzae, transplacental transfer, in Mexican mothers, 1047 Adherence HIV-I H. infiuenzae, to mammalian extracellular matrix, 1137 in cervicovaginal secretions, risk of viral transmission to infants, P. falciparum, and rosetting, 691 1001 Adhesins, E. coli, PCR detection of papG, 920 response in long-term nonprogressors, 60 AIDS (See human immunodeficiency virus infection) HTLV-I pX gene mutant products, 1115

AIDS Clinical Trials Group N. meningitidis, in children and adolescents, 1009 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 HIV envelope vaccine, protocol 137, 1336 P. aeruginosa, in CF patients, 513, 514 pediatric infection, low-dose zidovudine for, protocol 128, 1097 P. falciparum, 765 American visceral leishmaniasis, IL-12 role in, 1515 pneumococcal vaccine, for HIV-I infection, 83 Amocarzine, for 0. volvulus infection, 773 S. agalactiae type III capsular polysaccharide, 142 Amphotericin B S. mansoni, in recently-exposed Senegal community, 1232 colloidal dispersion, for invasive fungal infection, in transplant S. pneumoniae recipients, 1208 capsular polysaccharide, response, in elderly, 387 lipid complex, for visceral leishmaniasis, 762 in otitis media, in children, 136 Animal model APACHE II score, use in S. aureus bacteremia, to predict outcome, 914 B. burgdorferi, flagella-less mutant, as vaccine, in Lyme disease, Artemisinin derivatives, effect on P. falciparum adherence and rosetting, mouse, 1184 691 catheter, minocycline/rifampin coating, efficacy, rabbit, 418 Atherosclerosis, absence of C. pneumoniae coronary atheromas, 957 C. burnetti infection, acute, route, mouse, 484 C. glabrata vaginitis, mouse, 425 CMV retinitis, liposome-encapsulated cidofovir for, rabbit, 18 Bacteremia E. coli enterococcal, superoxide production in, 743 enterotoxin, immunization, antibody response, 1428 GAS, TNF-a role, 619 septic shock, prevention by tyrosine kinase inhibitor, mouse, 927 gram-negative, vaccine against, 1157 GBS meningitis, kynurenic acid for, neuroprotective effect, neonatal H. injiuenzae, nonencapsulated, 180 rat, 166 MAC, treatment, mouse model, 750 HCV infection, postexposure prophylaxis, chimpanzee, 822 S. aureus, nosocomial, APACHE II use in, 914 HIV-I vaccine, chimpanzee, 52 Bactericidal/permeability-increasing protein, on monocyte surface, 252 HSV infection, neonatal, antibody and acyclovir for, guinea pig, I Bartonella quintana, seroprevalence, at community clinic, in Seattle, HSV-I, latency and reactivation, mouse, 291 1023 HSV-2 genital infection, DNA immunization against, guinea pig, 800 Big endothelin, in P. falciparum malaria, 1281 HTLV-I pathogenesis, rabbit, 722 Bordetella pertussis, infection, seroepidemiology, in persons 1-65 K. pneumoniae infection, macrophage inflammatory protein for, years, 1256 mouse, 159 Borrelia burgdorferi infection L. donovani, relapse, mouse, 1041 cytokines for, 187 L. major, chemotherapy for, effect of polarity to T cell response, flagella-less mutant, as vaccine, in murine Lyme disease, 1184 mouse, 979 public health impact, in Maryland, 1260 MAC infection, bacteremia, treatment, mouse, 750 Borrelia lonestari sp. nov., identification in hard tick A. americanum, P. aeruginosa sepsis, neutropenic rat, immunotherapy for, 1415 403 papillomavirus, DNA vaccine against, rabbit, 314 Borrelia species, epidemiologic and diagnostic studies, 1527, 1528 parainfluenza virus type 3, bronchiolitis and pneumonia, treatment for, Bronchiolitis, parainfluenza type 3, treatment, cotton rat model, 598 cotton rat, 598 Burkitt's lymphoma, EBV DNA loss in, 529 P. carinii pneumonia, in transgenic B cell-deficient mouse, 1034 Candida albicans nitric oxide and host defense, mouse, 432 cell wall, and enolase, 684 Q fever, acute, infection route, mouse, 484 macrophage activity against, myeloperoxidase role in, 1202 S. pneumoniae Candida glabrata, vaginitis, mouse model, 425 otitis media, polysaccharide-protein conjugate vaccines for, Candida species, infection, oroesophageal, fluconazole resistance, in chinchilla, 119 HIV infection, 219 pneumonia, immunotherapy for, leukopenic mouse, 1123 Carcinoma, hepatocellular, association with HBV and HCV, in PspA, cross-protection, mouse, 380 Japanese-Americans, 1474 Catalase-peroxidase gene, characterization, in M. tuberculosis. 196 Catheter The Journal oflnfectious Diseases 1996; 173:1541-7 minocycline/rifampin coating, efficacy, rabbit model, 418 1542 Subject Index JID 1996;173 (June

silver iontophoretic, antiinfective prototype, 495 EIA to detect CD4 epitope masking, in HIV infection, 565 HBV and HCV, in syringes, 997 CD4-IgG, HIV-I inactivation, 863 measles virus, 1470 CDl4 receptors, role in multinucleated giant cells, 1194 Elephantiasis, W bancrofti, cytokines in, 1453 Ceftazidime, resistance, in K. pneumoniae, 151 ELISA to detect Cervical infection, HPV, persistence, 794 C. immitis spherule antigen, in CSF, 499 Chancroid, host response, in human experimental infection, 394 Coccidioides antibody, 1273 Chemokines, in leishmaniasis, 699 GBS III capsular polysaccharide-specific IgM antibody, 142 Chlamydia infection, as risk factor for HIV infection, in women, 1520, S. pneumoniae capsular polysaccharide antibody, 113 1521 Encephalitis Chlamydia pneumoniae infection, in coronary tissue, 957, 1519 T. gondii, in AIDS, genetic regulation of susceptibility, 265 Chlamydia trachomatis infection Toxoplasma PID, among sex workers in Nairobi, Kenya, 1437 folic acid supplements to pyrimethamine-sulfadiazine for, 1294 serology, 609, 1394 in HIV infection, pyrimethamine prophylaxis, 91 in STD core group, epidemiology, 950 Endocarditis, E. faecium, vancomycin-resistant, cell wall-active agents Chronic fatigue syndrome, immunologic diagnostic tests, 460 for, 909 Cidofovir, for CMV, human, 987 Endothelial injury, by N. meningitidis, 172 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Clofazimine, for MAC infection, 677 Enolase, in C. albicans cell wall, 684 Coccidia, taxonomy, 440 Entamoeba histolytica, alcohol/aldehyde dehydrogenase, 226 Coccidioides immitis, meningitis, antibody detection, 499 Enterococci Complement activation, N. meningitidis, septic shock, 647 glycopeptide resistance, natural reservoir in healthy persons, 1129 Coronary atherectomy, C. pneumoniae, 1519 vancomycin, oral vs. iv administration, resistance development, 1292, Coxiella burnetti, infection, route, mouse model, 484 1293 Cryptococcus neoformans Enterococcus faecalis, superoxide, extracellular, production, 743 interaction with murine macrophage-like cell, opsonin effect on, 1222 Enterococcus faecium, endocarditis, vancomycin-resistant, cell wall­ meningitis, experimental, fluconazole and flucytosine for, 1216 active agents for, 909 RAPD analysis, in immunosuppressed patients, 754 Enterotoxin Cryptosporidium parvum, infection, intensity and oocyst excretion E. coli patterns, 232 heat-stable, distribution among E. coli, 1019 Cyclospora, molecular genetic analysis, relation to Eimeria, 440 immunization, systemic and mucosal antibody response, 1428 Cystic fibrosis, P. aeruginosa, antibody in, 513, 514 mucosal immunogenicity of, 627 Cytokines staphylococcal, food poisoning, 1263 HFRS,38 Epidemiology measurements, in nasal lavage fluid, markers of dilution, 1049, 1050 B. burgdorferi infection, public health impact, in Maryland, 1260 in syphilis, 491 B. pertussis antibody, in persons 1-65 years, 1256 Cytomegalovirus infection B. quintana, seroprevalence, at community clinic, in Seattle, 1023 cidofovir susceptibility, 987 C. trachomatis infection ganciclovir resistance, CNS disease, 1481 PID, among sex workers in Kenya, 1437 of hematopoietic cells in tissue, 240 in STD core group, 950 in HIV-1-infected and - uninfected women, 77 E. coli OI57:H7, outbreak, 480 of leukocytes, 503 hantavirus pulmonary syndrome, 237, 781, 1297 neutralization by CDl3-specific antibody, 1062 hepatitis, incidence, among mus, 579 PCR detection, predictor of CMV disease, 1072 hepatitis C, genotypes in Spain, 509, 511 pneumonia, diagnosis, 1297 HIV infection resistance, ganciclovir, 523 cervicovaginal shedding, transmission risk to infants, 100I retinitis, liposome-encapsulated cidofovir for, rabbit model, 18 incidence, among IDUs, 579 T cell response to, 1051 S. pneumoniae infection in, 857 viremia, in liver transplant recipients, prognostic significance, 446 HIV-2, provirus load, community-based study, in Africa Cytotoxic T lymphocytes HPV against HCV, 24 neoplasia, cervical, prevalence, in Jamaican women, 718 in HIV infection, in long-term nonprogressor, 476 serology, markers of sexual behavior, 1394 HTLV-I morbidity, among carriers, in Japan, 585 Didanosine for HIV infection Lyme disease, epidemiologic and diagnostic studies, 1527, 1528 and IFN-a, phase IIII trial, 840 measles virus, molecular, 32 in multidrug combinations, 355 M. tuberculosis, infection, pregnancy as risk factor for, in HIV population pharmacokinetics, 273 infection, 488 virus phenotype changes, 1092 pregnancy, risk factor for tuberculosis, in HIV infection, 488 and zidovudine or zalcitabine and zidovudine combination therapy, small round-structured virus, gastroenteritis, outbreak, molecular vs. zidovudine monotherapy, 1354 investigation, 787 Diethylcarbamazine, for onchocerciasis, posttreatment eosinophilia, 1277 S. pneumoniae infection Diphtheria, antitoxin, in US blood and plasma donors, 1493 in HIV infection, 857 DNA recombination, EBV, in Burkitt's lymphoma, 529 resistant, spread in hospitalized children, in Slovakia, 374 Staphylococcus enterotoxin, food poisoning, canned mushrooms, 1263 Ehrlichia equi, infection, and antibody, 1027 surgical site infection, after hospital discharge, 963 JID 1996; 173 (June) Subject Index 1543

Vibrio infections, in Florida, 1981-1993, 1176 Haemophilus ducreyi Epstein-Barr virus adherence, to mammalian extracellular matrix, 1137 DNA recombination, in Burkitt's lymphoma, 529 antibody, transplacental transfer, in Mexican mothers, 1047 sequence variation in LMP-I, in hairy leukoplakia, 710 host response, in human experimental infection, 394 seronegative adults, immunologic properties, 1248 nonencapsulated, virulent, 180 Errata Hairy leukoplakia, sequence variation EBV LMP-I, 710 Anzala et aI., 1995;171:686-9, 1529 Hantavirus, HFRS, cytokine levels in, 38 Bemard et aI., 1994; 170:1077-85,516 Hantavirus pulmonary syndrome Heneine et aI., 1995; 171:1210-6, 1529 genomic sequences, in rodents and humans, 781 Papillomavirus series, 1994; 170:1075-99,516 incidence, in Baltimore, 237 Rennels et aI., 1996; 173:306-13, 1529 US cases, 1297 Salmon-Ceron et aI., 1995; 172:656-64, 277 Helicobacter pylori, coccoid forms, 1288 Tsai et aI., 1995; 171:1338-43,277 Helicobacter pylori-related diseases, virulence factors, 1171 Watson et aI., 1996; 173:731-4,1529 Hemagglutinin, recombinant vaccine, against influenza, in adults, 1467 Escherichia coli Hemorrhagic fever with renal syndrome, hantavirus infection, cytokine enterotoxin levels in, 38 heat-stable, distribution among E. coli, 1019 Hepatitis Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 immunization, oral, cytokine induction in, 1428 incidence, among IDUs, 579 labile, mucosal immunogenicity of, 627 in syringes, used, sensitivity of detection techniques, 997 J5 LPS, vaccine, 1157 Hepatitis A virus, vaccine, attenuated, simian strain protects OI57:H7, outbreak, 480 chimpanzees, 592 papG variants, PCR detection, 920 Hepatitis B virus, mutants, in HDV superinfection, 457 sepsis, hematoregulatory peptide SK&F 107647 for, 203 Hepatitis Band C, hepatocellular carcinoma association, in Japanese­ septic shock, prevention by tyrosine kinase inhibitor, mouse model, Americans, 1474 927 Hepatitis C virus Ethanol, effect on HIV replication, 550 CTL, peptide vaccine for, 24 genotypes, in Spain, 509, 511 Famciclovir, for HSV-I infection, mouse model, 291 infection Farr assay, modified, to measure S. pneumoniae capsular polysaccharide GOR antibody in, 300 antibody, 113 heterogeneity, during IFN-a therapy, 992 Fasciitis, necrotizing, S. pyogenes, 90 I prophylaxis, postexposure, in chimpanzees, 822 Filariasis due to W. bancrofti serotypes 1-6, 727 cytokines in, 769, 1453 structural proteins, immune response, in humans and chimpanzees, PCR detection, 1510 808 Fluconazole Hepatitis D virus, superinfection, HBV mutants in, 457 for C. neoformans meningitis, experimental, 1216 Hepatocellular carcinoma, association with HBV and HCV, in Japanese­ resistance, in candidiasis, in HIV infection, 219 Americans, 1474 Flucytosine, for C. neoformans meningitis, experimental, 1216 Herpes simplex virus Folic acid, supplements, to pyrimethamine-sulfadiazine, for Toxoplasma CD4 and CD8 lymphocyte cytotoxicity, 7 encephalitis, 1294 infection Foscarnet, risk for Kaposi's sarcoma, Multicenter AIDS Cohort study, neonatal, antibody and acyclovir for, guinea pig model, I 1477 type I, latency and reactivation, mouse model, 291 Four Corners hantavirus, epidemiology, 781 type 2 Fungal infection, invasive, in transplant recipients, amphotericin B genital, DNA immunization against, guinea pig model, 800 colloidal dispersion for, phase I study, 1208 vaccine against, 536 Furunculosis, recurrent, vitamin C for, 1502 type 8, Kaposi's sarcoma in, 248 Hodgkin's disease, pneumococcal conjugate vaccine, after treatment, Ganciclovir 256 CMV resistance, CNS disease, 1481 HU-211, nonpsychotropic cannabinoid, for S. pneumoniae meningitis, risk for Kaposi's sarcoma, Multicenter AIDS Cohort study, 1477 735 Gastroenteritis, small round-structured virus, outbreak, molecular Human granulocytic ehrlichiosis, cause of undifferentiated fever, 1027 investigation, 787 Human herpesvirus 8, presence in lymphoid system, in AIDS, 542 Glucocorticosteroid, for parainfluenza type 3 bronchiolitis and Human immunodeficiency virus type I infection pneumonia, cotton rat model, 598 acyclovir for, survival in, 504, 505 Gonorrhea (See Neisseria gonorrhoeae) of alveolar macrophages, from smokers, iron and HIV replication in, GOR epitope, in chronic HCV infection, 300 1045, 1046 Granulocyte-macrophage colony-stimulating factor, role in posttreatment antibody responses, in long-term nonprogressors, 60 eosinophilia, in onchocerciasis, 1277 antiretroviral monotherapy for, effect on virus load, 849 Group A streptococcus, bacteremia, TNF-a role, 619 CD4 epitope concentration ratio, as marker of progression, 565 Group B streptococcus CD4-IgG inactivation and binding, 863 antibody, naturally acquired, 142 cell-associated virus load, and T lymphocytes, 468 disease, invasive, serotype V emergence, 365 cervicovaginal shedding, transmission to infants, risk, 100I meningitis, kynurenic acid for, neuroprotective effect, CMV infection in, in women, 77 neonatal rat model, 166 CTL response, in long-term nonprogressor, 476 1544 Subject Index lID 1996; 173 (June)

ddI for IgG4 antibody, to S. haematobium, response after chemotherapy, in HIV phenotype changes, 1092 adults and children, 1242 and IFN-a for, phase 1/11 trial, 840 IgM EIA, to detect measles virus, 1470 population pharmacokinetics in, 273 Impetigo, S. pyogenes. genetic markers, 896 effect on antibody response to pneumococcal vaccine, 83 Infectious Diseases Society of America, Presidential Address, annual ethanol effect on replication, 550 meeting, 517 gpl20 vaccine, failure, mechanism of, 512 Influenza A virus heterosexual transmission, 1520, 1521 PMNL dysfunction, 279 HHV-8 reactivation in, 542 vaccine, 44, 285 HLA class I antibodies, in high-risk seronegative IDUs, 472 Influenza virus vaccine and HPV infection, cervical abnormalities, 714 inactivated, split vs, live attenuated, in Russian schoolchildren, 453 IFN-an3 for, phase I trial, 1107 live attenuated, safety, immunogenicity, and efficacy, in children, IL-2 effect on replication, 559 1313 IL-12 and anti-IL-IO effects on T cell function, 1085 recombinant hemagglutinin, in adults, 1467 incidence, among IDUs, 579 Interferon-a induced cell death, prevention, 1367 and didanosine, for HIV infection, phase IIII trial, 840

in infants, determination of infection status, 68 for HCV infection, HCV heterogeneity during therapy, 992 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 iron supplementation in, 1044, 1045 production, in EBV-seronegative adults, 1248 lamivudine or stavudine multiple drug combinations for, 355 Interferon-an3, for HIV infection, phase I trial, 1107 long-term, prognostic value of viremia, 1388 lnterferon-y maternal, maternal-fetal transfer of IgG immunity, 1077 for B. burgdorferi infection, 187 neutralizing antibody, 340 in T. pallidum phagocytosis, 491 pediatric, 574, 1097, 1327, 1485 Interleukin-2 PEG-IL-2 and thymosin a[cfl5] I for, 1005 for B. burgdorferi infection, 187 P. marneffei infection in, seasonal variation, in Thailand, 1490 effect on HIV replication, 559 pneumococcal polyethylene glycol-modified, for HIV infection, 1005 infection, in children, 870 Interleukin-5, role in posttreatment eosinophilia, in onchocerciasis, 1271 vaccine in, 777, 778 Interleukin-6 prognostic parameters, 1522, 1523 levels in HFRS, 38 progression, 877, 1526 production, in EBV-seronegative adults, 1248 protease inhibitors, 321, 1524, 1525 Interleukin-8, release, in response to sCDI4 and LPS, 661 resistance, in vivo, to saquinavir, 1379 Interleukin-IO retinol levels in, 507, 507 in CSF, of children with bacterial meningitis, 1498 S. pneumoniae infection in, epidemiology, 857 production, in human lymphatic filariasis, 769 sTNFaRII in, 464 role, in growth in Mycobacterium avium, 410 T. gondii encephalitis in, genetic regulation of susceptibility, 265 Interleukin-12 vaccine effect on T cell immune function, in HIV-infected persons, 1085 chimpanzee model, 52 in visceral leishmaniasis, IL-12 role in, 1515 envelope subunit, 340 Iron immune response, ACTG protocol 137, 1336 and oxidative stress, effect on HIV replication, 1045, 1046 safety and immunogenicity, 330 supplementation, in HIV infection, 1044, 1045 virus load Isoniazid resistance, in M. tuberculosis, 196 phenotype, and clonal composition, 349 stavudine effect on, 1252 Kaposi's sarcoma zidovudine and zalcitabine or ddI combination therapy vs. zidovudine herpesvirus in, 248 monotherapy for, 1354 risk factors, Multicenter AIDS Cohort study, 1477 Human immunodeficiency virus type 2, infection, provirus load, Klebsiella pneumoniae infection community-based study, in Africa ceftazidime resistance in, 151 Human papillomavirus infection macrophage inflammatory protein for, mouse model, 159 and cervical neoplasia, prevalence, in Jamaican women, 718 resistance, to ,B-Iactam-,B-Iactamase inhibitor combinations, 151 and HIV infection, cervical abnormalities in Malawi women, 714 Kynurenic acid, for GBS meningitis, neuroprotective effect, neonatal rat persistence in cervix, 794 model,166 serology, markers of sexual behavior, 1394 Human T cell leukemia virus type I infection morbidity, among carriers, in Japan, 585 Lamivudine, for HIV-I infection, in multidrug combinations, 355 pX gene mutant products, antibody to, 1115 Latent membrane protein-I, EBV, sequence variation, 710 rabbit model, 722 Leishmania chagasi American visceral leishmaniasis, IL-12 role in, 1515 IgE antibody, to S. haematobium, response after chemotherapy, in adults recombinant antigen, as predictor of visceral leishmaniasis, 758 and children, 1242 Leishmania donovani, relapse models, mouse model, 1041 IgG Leishmania major, chemotherapy for, effect of polarity to T cell antibody, to pneumococcal capsular polysaccharide, in HIV infection, response, mouse model, 979 1347 Leishmaniasis immunity, maternal-fetal transfer, HIV-infected mothers, 1077 chemokine expression in, 699 IgG-binding proteins, S. pyogenes, 888 cutaneous, chemokine role, 699 JID 1996; 173 (June) Subject Index 1545

visceral, amphotericin B lipid complex for, 762 Mycobacterium tuberculosis Leukocyte, CMV infection of, 503 detection by PCR and strand displacement amplification, 934 Lipopolysaccharide isoniazid resistance, 196 E. coli, toxicity, prevention by tyrosine kinase inhibitor, mouse Mycoplasma pneumoniae model, 927 detection by PCR, 1445 hyporesponsiveness of M. avium-infected macrophages, 1030 respiratory infection, pediatric, 1445 IL-8 release via sCDI4, 661 Myeloperoxidase, role in macrophage candidicidal activity, 1202 N. gonorrhoeae, sialylation effect, 1422 Lipopolysaccharide-specific protein, BPI, on monocyte surface, 252 Necrotizing fasciitis, S. pyogenes, mouse model, 1399 Liver Neisseria gonorrhoeae disease, and risk of Vibrio infection, 1176 infection, urethral, pathogenesis, 636 transplant recipients, CMV viremia in, prognostic significance, 446 infectivity, sialylation effect, 1422 Lyme disease (See Borrelia infection) Neisseria meningitidis Lymphocyte, CD4 and CD8, cytotoxicity for HSV-infected antibody response, in children and adolescents, 1009 keratinocytes, 7 inflammatory response to, 172 septic shock

Macrophage Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 complement activation, 647 alveolar, from smokers, iron and HIV replication in, 1045, 1046 inflammatory mediators and hemostatic parameters, 1148 inflammatory protein Neutrophil, dysfunction, in influenza A, 279 la and 1,6, in leishmaniasis, 699 Nevirapine, for HIV-I infection, in multidrug combinations, 355 2, for Klebsiella pneumonia, mouse model, 159 Nitric oxide synthase, production, in bovine and caprine macrophages, NO synthase production, in ruminants, 971 971 Major outer membrane protein, C. trachomatis, 609, 950 Norwalk-like viruses, diagnosis, 787 Malaria Nosocomial infection, O. anthropi meningitis, in pericardial tissue case definition in, 275, 276 transplant recipients, 656 mefloquine prophylaxis, long-term, in Dutch marines, 1506 PCR-based liquid hybridization assay, for diagnosis, 1284 P. falciparum Ochrobactrum anthropi, meningitis, in pericardial tissue transplant clinical immunity, 765 recipients, 656 cytoadherence and rosetting, inhibition by antimalarials, 691 Onchocerca volvulus, detection by PCR, 773 Marrow transplant, fungal infection in, amphotericin B colloidal Onchocerciasis, diethylcarbamazine for, posttreatment eosinophilia, 1277 dispersion for, 1208 Oocyst, C. parvum, infection, excretion patterns, 232 Measles, mumps, rubella, and varicella, vaccine, combined, safety and Opsonin, effect on C. neoformans interaction with murine macrophage­ immunogenicity, 731 like cell, 1222 Measles virus Otitis media detection by IgM EIA, 1470 H. infiuenzae, bacteremia in, 180 epidemiology, molecular, 32 S. pneumoniae vaccine, immune response, in infants, 1320 antibody-secreting cells, in children, 136 Mefloquine, prophylaxis, long-term, for malaria, in Dutch marines, 1506 polysaccharide-protein conjugate vaccines for, chinchilla model, Meningitis 119 bacterial, pediatric, IL-IO in CSF, 1498 C. immitis, serologic diagnosis, 499 p24 antigen, in HIV-I infection, pediatric, 68, 574 C. neoformans, experimental, fluconazole and flucytosine for, 1216 Papillomavirus GBS, kynurenic acid for, neuroprotective effect, neonatal rat model, human 166 and HIV infection, cervical abnormalities in Malawi women, 714 H. infiuenzae, nonencapsulated, 180 persistence in cervix, 794 0. anthropi, in pericardial tissue transplant recipients, 656 serology, markers of sexual behavior, 1394 S. pneumoniae, HU-21I, nonpsychotropic cannabinoid for, 735 rabbit, DNA vaccine for, 314 tuberculous, pathogenesis, 1194 Parainfluenza virus type 3, bronchiolitis and pneumonia, treatment for, Microangiopathy, thrombotic, pathogenesis, Shiga toxin effects on, 1164 cotton rat model, 598 Microglia, M. bovis interaction with, 1194 Pelvic inflammatory disease, C. trachomatis, among sex workers in Minocycline/rifampin, catheter coating, efficacy, rabbit, 418 Nairobi, Kenya, 1437 Monoclonal antibody, against C. neoformans, 1222 Penicillium mameffei, infection, disseminated, in AIDS, seasonal Monocyte chemoattractant protein-I, in leishmaniasis, 699 variation, in Thailand, 1490 Mycobacterium avium complex infection Phagocytosis, and intracellular killing of Candida, 1202 bacteremia, treatment, mouse model, 750 Pharyngitis, S. pyogenes, genetic markers, 896 disseminated Plasminogen, staphylokinase, S. aureus, 104 blood and tissue burden, 942 Plasmodium falciparum malaria in AIDS, TNF-a and 1,25 dihydroxyvitamin D, 259 big endothelin in, 1281 sputum isolates, 263 case definition in, 275, 276 treatment for, 677 clinical immunity, 765 Mycobacterium avium cytoadherence and rosetting, artemisinin derivatives, 691 infected macrophages, hyporesponsiveness to LPS, 1030 Plasmodium infection, PCR-based liquid hybridization assay, for intracellular growth, IL-IO role in, 410 diagnosis, 1284 Mycobacterium bovis, interaction with microglia, 1194 Pneumococcal conjugate vaccine, priming, antibody response, 256 1546 Subject Index JID 1996; 173 (June)

Pneumocystis carinii infection Sepsis pneumonia, in transgenic B cell-deficient mice, 1034 E. coli, hematoregulatory peptide SK&F 107647 for, 203 nitric oxide and host defense, mouse model, 432 pneumococcal, recombinant PspA, 380 Pneumonia S. aureus, hematoregulatory peptide SK&F 107647 for, 203 CMV, diagnosis, 1297 Septata intestinalis, infection, latent, in HIV infection, 1038 hantavirus, community-acquired, in Baltimore, 237 Septic shock K. pneumoniae, macrophage inflammatory protein for, mouse model, E. coli LPS-induced, prevention by tyrosine kinase inhibitor, mouse 159 model, 927 M pneumoniae, pediatric, PCR detection, 1445 N meningitidis, 647, 1148 parainfluenza type 3, treatment, cotton rat model, 598 P. aeruginosa, experimental, combination immunotherapy for, P. carin ii, in transgenic B cell-deficient mouse, 1034 neutropenic rat model, 1415 S. pneumoniae, immunotherapy for, 1123 S. epidermidis, induction of TNF-a release, 212 Poliovirus, vaccine, oral, and rotavirus vaccine, concurrent, 306 soluble CDI4 function, 661 Polyethylene glycol-modified IL-2, for HIV infection, 1005 Shiga toxin, effects on endothelial cells, 1164 Polymerase chain reaction to detect Simian immunodeficiency virus, vaccine, administration to mothers, CMV, 523, 1072, 1481 effect on neonates, 1327

cytokine mRNA, in syphilis lesions, 491 Sin Nombre hantavirus, epidemiology, 781 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 E. coli papG variants, 920 Small colony variants, S. aureus, induced by endothelial cells, 739 HBV and HCV, in syringes, 997 Small round-structured virus, gastroenteritis, outbreak, molecular HIV-I, in infants, 68 investigation, 787 human granulocytic ehrlichiosis, 1027 Smoking, as risk factor for HIV infection, in women, 1520, 1521 M pneumoniae, 1445 Staphylococcus, enterotoxin, food poisoning, 1263 M tuberculosis, 934 Staphylococcus aureus 0. volvulus, 773 bacteremia, nosocomial, APACHE II use in, 914 S. intestinalis latent infection, in HIV infection, 1038 furunculosis, recurrent, vitamin C for, 1502 W bancrofti, 1510 sepsis, hematoregulatory peptide SK&F 107647 for, 203 Polymerase chain reaction-based sequence-specific oligonucleotide small colony variants, induced by endothelial cells, 739 hybridization analysis, in pulmonary tuberculosis, 669 staphylokinase, plasminogen, 104 Polyradiculopathy, ganciclovir-resistant CMV, 1481 TSST-I, production, effect of tampon composition, 98,1289,1290 Polysaccharide, capsular, S. pneumoniae, 113, 1347 Staphylococcus epidermidis, peptidoglycan, induction of TNF-a release, Pregnancy, risk factor for tuberculosis, in HIV infection, 488 212 Presidential address, IDSA annual meeting, 517 Staphylokinase, S. aureus, plasminogen, 104 Protease, S. mansoni larvae, infectivity, 1460 Stavudine, for HIV-I infection, 355, 1252 Pseudomonas aeruginosa Strand displacement amplification, to detect M tuberculosis, 934 cystic fibrosis, antibody in, 513, 514 Streptococcal toxic shock syndrome, Vf3 repertoire in, 274 sepsis, neutropenic rat model, immunotherapy for, 1415 Streptococcus agalactiae, serotype V, emergence of, 365 Pulsed-field gel electrophoresis, for E. coli 0157:H7 outbreak analysis, Streptococcus pneumoniae 480 infection Puumala virus, HFRS, cytokine levels in, 38 in HIV infection, 857, 870 Pyrimethamine, prophylaxis, for Toxoplasma encephalitis, in HIV invasive, subtyping, 128 infection, 91 meningitis, nonpsychotropic cannabinoid for, 735 Pyrimethamine-sulfadiazine for, Toxoplasma encephalitis, folic acid otitis media, 119, 136 supplements to, 1294 pneumonia, immunotherapy for, 1123 resistant, spread in hospitalized children, 374 Q fever, acute, infection route, mouse model, 484 polysaccharide capsular, antibody to, measurement by Farr assay vs. ELISA, 113 vaccine, 380, 387, 777, 778, 1014, 1347 Random amplification of polymorphic DNA, in immunosuppressed Streptococcus pyogenes patients, 754 IgG-binding proteins, 888 Respiratory syncytial virus, vaccine, attenuated, immunogenicity in infection, invasive, genetic and phenotypic diversity, 901 rodents and nonhuman primates, 829 isolates, genomic heterogeneity, 896, 901 Retinitis, CMV, liposome-encapsulated cidofovir for, rabbit model, 18 necrotizing fasciitis, mouse model, 1399 Rifampin, for MAC infection, 677 toxic shock syndrome, Vf3 repertoire in, 274 Ritonavir, for HIV infection, immune response, 321 toxin production, in sepsis, 1399 Rotavirus, vaccine, and oral poliovirus vaccine, concurrent, 306 Superoxide, E. faecalis, extracellular, production, 743 Surgical site infection, after hospital discharge, 963 Saquinavir for HIV-I infection Syncytium-inducing phenotype, HIV, changes in, after ddI, 1092 HIV resistance to, in vivo, 1379 Syphilis, cytokine response in, 491 in multidrug combinations, 355 Schistosoma haematobium, infection, in adults and children, IgG4 and T cell IgE responses after chemotherapy, 1242 function, IL effect in HIV-infected persons, 1085 Schistosoma mansoni infection response, to CMV glycoprotein H, 1051 antibody response pattern, in Senegal, 1232 subsets, in HIV infection, and virus load, 468 larval protease role, 1460 Tetanus toxoid response impairment, in human S. mansoni infection, tetanus toxoid response impairment, in humans, 269 269 JID 1996;173 (June) Subject Index 1547

Toxic shock syndrome, S. pyogenes, 901 HSV-2 genital infection, animal model, 800 Toxic shock syndrome toxin-I, production, tampons composition, 98, influenza, 44, 285, 453, 1313, 1467 1289, 1290 Lyme disease, B. burgdorferi flagella-less mutant, mouse model, 1184 Toxoplasma encephalitis measles, mumps, rubella, and varicella, combined, 731 in AIDS measles virus, immune response, in infants, 1320 genetic regulation of susceptibility, 265 poliovirus, oral, and rotavirus vaccine, concurrent, 306 pyrimethamine prophylaxis, 91 rotavirus, and oral poliovirus vaccine, concurrent, 306 folic acid supplements to pyrimethamine-sulfadiazine for, 1294 RSV, attenuated, immunogenicity in rodents and nonhuman primates, Treponemapallidum, infection, cytokine response, 491 829 Tuberculosis SlY, administration to mothers, effect on neonates, 1327 lymphocytes, alveolar, 1267 S. pneumoniae, 83, 119,256,380,387, 1014, 1347 pulmonary, disease severity, HLA association for, 669 typhoid fever, human trial, 1408 Tumor necrosis factor-a viral, nucleic acid, against HSV-2, 536 for B. burgdorferi infection, 187 zoster, effect of boosting, in leukemic children, 450 in disseminated MAC infection, in AIDS, 259 Vaginitis, C. glabrata, mouse model, 425 in GAS bacteremia, 619 Vancomycin

in HFRS, 38 iv vs. oral, resistance development in enterococci, 1292, 1293 Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 in multinucleated giant cells, 1194 and teicoplanin, effect on resistance of fecal flora, 1129 release, induction by S. epidermidis peptidoglycan, 212 Varicella-zoster virus, vaccine, effect of boosting, in leukemic children, soluble receptor 450 in CSF, of children, in bacterial meningitis, 1498 Vesicourethral reflux, avoidance, in UTI, mouse model, 746 in HIV infection, 464 Vibrio species, infections, in Florida, 1981-1993, 1176 Typhoid fever, phoP/phoQ-deleted S. typhi as vaccine, human trial, Virulence 1408 H. influenzae, noncncapsulated, 180 Tyrphostins, protective effect, against LPS toxicity, in E. coli-infected H. pylori, 1171 mice, 927 Visceral leishmaniasis, relapse models, 1041 Vitamin A, deficiency, in HIV infection, 507, 509 Upper respiratory infection, cytokine measurements in, markers of Vitamin C, for furunculosis, in patients with impaired neutrophil dilution, 1049, 1050 function, 1502 Urethral infection, N. gonorrhoeae, electron microscopic analysis of, Wucheria bancrofti, infection 636 cytokines in, 1453 Urinary tract infection IL-IO production in, 769 E. coli, papG variants, 920 PCR detection, 1510 mouse model, inoculation conditions, 746 Zalcitabine, and zidovudine or ddl combination therapy vs. zidovudine vf3 repertoire, in streptococcal toxic shock syndrome, 274 monotherapy for HIV infection, 1354 Vaccine Zidovudine for HIV infection DNA, against rabbit papillomavirus, 314 effect on virus load, 849 E. coli J5 LPS, vaccine, 1157 in multidrug combinations, 355 HAV, attenuated, simian strain protects chimpanzees, 592 pediatric, low-dose, ACTG 128, 1097 HCV, peptide, for HCV-specific CTL induction, 24 and zalcitabine or ddl combination therapy vs. zidovudine HIV-I, 52, 330, 340, 512,1336 monotherapy, 1354 Infectious Diseases Society of America

OFFICERS Samuel L. Katz Donald Armstrong Raleigh A. Bowden Donald Armstrong, President John W. Olds P. Frederick Sparling Bruce G. Gellin P. Frederick Sparling, President­ Donald M. Poretz John E. Bennett Michel P. Glauser Elect William Schaffner Merle A. Sande Eduardo H. Gotuzzo Gilbert M. Schiff Peter A. Gross John E. Bennett, Vice-President WORKFORCE Catherine M. Wilfert, Secretary­ Daniel J. Sexton Gerald L. Mandell Treasurer Stephan E. Lawton, Legal Counsel Theodore C. Eickhoff, Chair Francoise Meunier Vincent T. Andriole Larry K. Pickering Vincent T. Andriole, Past-President AD HOC COMMITTEES Stephen G. Baum W. Michael Scheid COUNCILLORS ACP COUNCIL Charles C. J. Carpenter Robert T. Schooley Carol J. Baker Jonathan W. M. Gold Elliot Goldstein Cynthia L. Sears Martin J. Blaser Bruce H. Hamory Leon G. Smith James W. Curran AIDS Elaine C. Jong P. Frederick Sparling Anne A. Gershon John P. Phair, Chair Jay P. Sanford Catherine M. Wilfert David N. Gilbert Bruce W. Polsky Lucy S. Tompkins John E. McGowan, Jr. Judith E. Feinberg Ellen R. Wald TASKFORCE ON HEALTH Lucy S. Tompkins Wayne L. Greaves Mark S. Klempner, ex-officio CARE REFORM Kenneth H. Mayer Thomas G. Slama, ex-officio Merle A. Sande, Chair STANDING COMMITTEES Grace Y. Minamoto Vincent T. Andriole Thomas C. Quinn PHARMACEUTICAL AFFAIRS AWARDS Theodore C. Eickhoff Merle A. Sande C. Douglas Webb, Chair David N. Gilbert Raphael Dolin, Chair Kathleen E. Squires Stephan A. Billstein Ellie J. C. Goldstein John N. Sheagren Catherine M. Wilfert David J. Pizzuti Peter A. Gross Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 John E. Bennett Hugh Rosen Charles M. Helms Robert L. Marier ANTIBIOTIC USE AND Constance D. Rothermel CLINICAL TRIALS King K. Holmes Claire V. Broome John L. Ryan Mark S. Klempner William A. Craig, Chair CLINICAL AFFAIRS PUBLIC RELATIONS Phillip L. Sanchez Michael Barza Jay P. Sanford Thomas G. Slama, Chair Raleigh A. Bowden Vincent T. Andriole, Co-Chair Daniel J. Sexton Steven J. Berman Anthony W. Chow Stephen H. Zinner, Co-Chair Thomas G. Slama Mark J. Kunkel George M. Eliopoulos Paul M. Arnow P. Frederick Sparling David B. Martin Joyce A. Korvick Constance A. Benson Richard P.Wenzel Daniel J. Sexton Francoise Meunier Janet R. Gilsdorf Barbara H. Wade Richard D. Meyer P. Samuel Pegram PROFESSIONAL Gregory R. Istre Alice S. Prince DEVELOPMENT AND STATE AND REGIONAL Bryan P. Simmons Fred C. Tenover EQUITY Mary H. White SOCIETIES Julie L. Gerberding, Chair ETHICS Michael Stek, Jr. David F. Busch Virginia D. Banks-Bright Paul G. Quie, Chair Linda Ann Sherman Bonnie V. Bock Jack M. Gwaltney, Jr. Claudio Viscoli TUBERCULOSIS Celia Christie Richard B. Hornick Wafaa M. EI-Sadr, Chair INFECTIOUS DISEASESI Ellen R. Cooper Adolf W. Karchmer Peter Barnes INTERNAL MEDICINE Monica M. Farley Robert L. Marier David L. Hom TRAINING PROGRAM Finegold Robert C. Horsburgh, Jr. FINANCE DIRECTORS John E. McGowan, Jr. Mary P. Glode Wayne L. Greaves Jerome O. Klein, Chair John G. Bartlett, Chair Barbara E. Robinson-Dunn Mary E. Guinan Martin J. Blaser Martin J. Blaser Kent A. Sepkowitz Lucy S. Tompkins Stephan A. Billstein K. Lynn Cates Robert Fekety Wafaa M. EI-Sadr FELLOWSHIP AND YOUNG Judith E. Wolf Abigail D. Zuger Ellie J. C. Goldstein Keith A. Joiner INVESTIGATOR GRANTS Mark S. Klempner AWARD Barbara E. Murray TASKFORCE ON THE VALUE Marvin Turck Carl W. Norden Ward E. Bullock, Chair Carmelita U. Tuazon OF THE INFECTIOUS Catherine M. Wilfert, ex-officio Carol J. Baker DISEASES SPECIALIST SUBCOMMITTEE OF THE Joshua Fierer NOMINATIONS Richard P. Wenzel, Chair PROGRAM DIRECTORS Robert T. Schooley Vincent T. Andriole, Chair Cynthia L. Sears David C. Classen John G. Bartlett, Chair Gerald L. Mandell Lucy T. Tompkins David S. Fedson Martin J. Blaser Merle A. Sande Sten H. Vermund Richard A. Garibaldi K. Lynn Cates Ann M. Arvin Joseph F. John, Jr. Theodore C. Eickhoff Francis A. Ennis PRACTICE GUIDELINES Ronald E. Polk Ellie J. C. Goldstein Peter A. Gross, Chair Michael Stek, Jr. Adolf W. Karchmer PUBLICATIONS Murray D. Batt Robert L. Thompson Mark S. Klempner Elias Abrutyn, Chair E. Patchen Dellinger Robert F. Woolson Anne A. Gershon INTERNATIONAL AFFAIRS Anne A. Gershon PUBLIC HEALTHIPREVENTIVE Lucy S. Tompkins COMMITTEE Peter J. Krause MEDICINE John E. McGowan, Jr. Richard L. Guerrant, Chair Dennis G. Maki Philip A. Mackowiak H. Erdal Akalin William J. Martone William Schaffner, Chair Charles V. Sanders A. Peter Ball John E. McGowan, Jr. Mary Lou Clements Carmelita U. Tuazon Helen Giamarellou Richard L. Sweet Bruce G. Gellin Sydney Finegold, ex-officio Hartmut M. Lode Richard P. Wenzel Anne A. Gershon Marvin Turck, ex-officio W. Paul Glezen Peter D. O'Hanley PROGRAM Catherine M. Wilfert, ex-officio Allan R. Ronald Samuel L. Katz Jerome O. Klein, Co-Chair Jane E. Koehler PUBLIC POLICY Rosemary Soave J. David Williams Lucy S. Tompkins, Co-Chair Donald Louria Charles M. Helms, Chair Sin-Yew Wong Donald Armstrong June E. Osborn K. Lynn Cates Vincent T. Andriole Philip K. Russell John E. Edwards, Jr. LONG-RANGE PLANNING John E. Bennett George R. Siber Michael B. Grizzard Vincent T. Andriole. Chair Steven .T. Rerman 7\Apl-intl-:l UTlvu-tnn Journal of Infectious Diseases Instructions for Authors

The Journal ofInfectious Diseases is sponsored by the Infec­ development. Concise Communications include a short abstract tious Diseases Society of America. Reports of research related to but are limited in length (no more than 2000 words) of text, two any aspect of the fields of microbiology and infection, whether inserts (tables or figures), and 15 references. laboratory, clinical, or epidemiologic, will be considered for publi­ Correspondence (letters). Only correspondence that is submitted cation in the Journal. Major articles and concise communications in reference to a previous publication in the Journal will be consid­ are, in general, peer reviewed; correspondence is reviewed by the ered. Correspondence regarding observations of unusual teaching Editors. or clinical value should be submitted to Clinical Infectious Dis­ eases. Please prepare the letter in manuscript format, including a title page. The letter cannot exceed 750 words of text, one insert Submission of the Manuscript (table or figure), and 10 references and does not carry acknowledg­ Submission of a manuscript to the Journal is regarded as a ments. Please submit one original of the manuscript and a high­ tacit declaration that the same material has not been submitted density disk for electronic editing; the program and format must or accepted for publication elsewhere. Effective I June 1995, all be specified. manuscripts submitted to the Journal must be accompanied by a Perspectives are invited and are overviews of articles in the letter declaring that the manuscript has not been submitted or Journal or of other research in infectious diseases. Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 accepted for publication elsewhere. This letter must be signed by Editorials may be on any aspect of infectious diseases. They all authors and must warrant that all authors have seen and ap­ are generally invited, but unsolicited editorials will be considered. proved the content and have contributed significantly to the work. Institutional Reports are summaries of workshops and reports A similar letter must accompany a revised submission. All authors from the National Institutes of Health or the Centers for Disease Control. Page charges may be required. should note that the Journal considers redundant publication a Reviews that are primarily basic in nature will be considered. serious matter requiring appropriate action. Manuscripts that describe both the basic and clinical aspects of Written permission must be obtained from all investigators cited disease may be submitted to either the JID or Clinical Infectious in a personal communication who are not coauthors of the present Diseases. Review articles will be peer-reviewed. manuscript and from the copyright owner if a previously published Supplements are published by the JID. Inquiries related to suit­ table or figure is to be reproduced. All letters ofpermission should ability of topic, program organization, and production should be accompany the submitted manuscript. Accompanying the manu­ made in writing to the Editor. script should be three copies of "in press" references and articles News from the Infectious Diseases Society ofAmerica carries by the same authors on the same subject submitted elsewhere. announcements of interest to the members of the IDSA. Please submit manuscripts to The Editor, the Journal ofInfec­ The Journal reserves the right to edit for Journal style, clarity, tious Diseases, 1910 Fairview Avenue E., Suite 210, Seattle, WA conciseness, precision of expression, and grammar. Authors review 98102-3603. Include the complete address, telephone and fax num­ these changes at the galley proof stage but must limit their alter­ bers, and e-mail address ofthe corresponding author. Each manu­ ations in proof to correcting errors and to clarifying misleading script is assigned a number; the corresponding author will be noti­ statements. fied of receipt of the manuscript and of the number assigned. This number should be used in all communications. Authors are encouraged to submit the names, addresses, and telephone numbers Manuscript Preparation of 4 persons who potentially could serve as unbiased and expert reviewers for their manuscript, but the Journal reserves the right The Journal complies with Uniform Requirements for Manu­ of final selection. The Journal will return only the original manu­ scripts Submitted to Biomedical Journals (Annals ofInternal Medi­ script and figures of papers not accepted for publication. cine 1982;96:766-70), except reference citations should appear in the text in square brackets (not parentheses). Both original and revised manuscripts must be typed or printed on white bond paper. Manuscript Categories All material, including tables, references, and legends, must be double-spaced. Indicate italic by underlining (e.g., genus and spe­ Major Articles describe original investigations that are an im­ cies names, genes, proteins) but not in vivo, in vitro, in situ, or et portant advance in the field and that have been brought to an al. (see a recent issue of the Journal for style). acceptable degree of completion. Although there is no length re­ Submit the original typescript and three copies with four sets striction, practical considerations require that the text, tables, and of illustrations. Each set of illustrations should be in an envelope. illustrations be limited to the minimum necessary for clear All pages, including the title page, must be numbered. Order and concise presentation. Manuscripts that are descriptive or pri­ all manuscript material in major articles and concise communica­ marily methodologic in nature must be submitted as concise com­ tions as follows: title page, footnotes to the title page, abstract, text, munications. acknowledgment, references, figure legends, tables, and figures. Concise Communications present a complete study that is nar­ Title page. Please supply a running head of not more than 40 rower in scope than one in a major article or that represents a new characters and spaces, a title of not more than 160 characters and spaces, the names and affiliations ofthe authors, and a word count of the abstract and of the text. Footnote page. Supply a separate page with footnotes to the The Journal of Infectious Diseases 1996 first page of the article. Footnotes must include (1) the name, date Instructions for Authors

(month and year), and location (city, state, country if not USA) ries ofthe potential problems, authors are referred to recommenda­ of a meeting at which all or part of the information has been tions that have appeared in the Journal (1984;149:349-54), in presented (include an abstract number if possible); (2) a statement JAMA (1966;195:1123-8), and in the British Medical Journal that informed consent was obtained from patients or their parents (1977;1:85-7 and 1983;286:1489-93). or guardians and that human experimentation guidelines ofthe US Units of measurement. Use degrees Celsius for temperature. Department of Health and Human Services and/or those of the The use ofSI units is encouraged (see Annals ofInternal Medicine authors' institution(s) were followed in the conduct of clinical 1987;106:114-29). All data should be expressed in metric units. research or that animal experimentation guidelines were followed Tables and figures. Tables should be concise and organized in animal studies; (3) a statement, if applicable, that an author has to show results clearly, not merely compilations ofraw data. Data a commercial or other association that might pose a conflict of should not be repeated in both a table and a figure. Abbreviations interest (e.g., pharmaceutical stock ownership); (4) sources of fi­ and acronyms used in tables and figures must be explained in the nancial support (including grant numbers); the name, address, tele­ table footnotes and figure legends. phone and fax numbers, and e-mail address ofthe person to whom Tables are numbered in the order of appearance in the text. proofs and requests for reprints should be addressed; and (5) cur­ Vertical and internal rules are not used. Footnotes and accompa­ rent affiliations and addresses for authors who have moved since nying explanatory material should be kept to a minimum. Foot­ completion of the study. notes should be placed below the table and are designated by the

Abstract. The abstract, one paragraph of not more than 150 following symbols (listed in order of location when the table is Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 words, should state the purpose ofthe research, the methods used, read horizontally): *, to t, §, II, ~, **, tt, etc. Each column must the results, and the conclusions. Write the abstract in third person; have an appropriate heading, and units ofmeasure must be clearly do not cite references in the abstract. Authors are reminded that indicated. the abstract is of particular value to producers and users of com­ Figures that are line drawings (black and white charts and puter-based literature retrieval systems such as the MEDLINE sys­ graphs) may be submitted as glossy photographs or as high-quality tem of the National Library of Medicine. laser prints on bond paper. Each graph or chart should incorporate References. References must be typed double-spaced. Only a key to the symbols used. Half-tone images (e.g., gels, photomi­ works that have been published or accepted for publication can crographs) must be submitted as glossy photographs. Each print be included. Unpublished observations by the authors, personal should be clearly labeled with the first author's name and the figure communications, and manuscripts submitted for publication should number. Legends should be typed double-spaced on a separate appear as parenthetical expressions in the text, e.g., (unpublished sheet of paper. Authors must pay the full cost for reproduction of data). Number references in order of appearance; those cited only color figures. Photomicrographs should show only the most perti­ or first in tables or figures are numbered according to the order in nent area of the material being studied or should be marked for which the table or figure is cited in the text. Example: If table 2 cropping. A micron bar or appropriate scale marking must appear is cited in the text after reference 25, a new reference cited in on the figure. table 2 will be reference 26. Style. Authors are referred to Scientific Style and Format. References must follow the format of the National Library of The CBE Manual for Authors, Editors, and Publishers. 6th ed. Medicine as used in Index Medicus and "Uniform Requirements" Bethesda, MD: Council ofBiology Editors, 1994) and the Chicago (see above). Provide all authors' (or editors') names when fewer Manual ofStyle (14th ed. Chicago: University of Chicago Press, than 7; when 7 or more, list the first 3 and add et al. Titles of 1993). joumals not listed in Index Medicus should be spelled out in full. For commercially obtained products mentioned in the text, list Reference to a doctoral dissertation should include the author, title, full names ofmanufacturers and locations (city, state, and country institution, location, year, and publication information, if pub­ if not USA). Generic names of drugs and other chemical com­ lished. Accuracy of references is the responsibility of the au­ pounds should be used. thors. Examples of the proper format are as follows: Proofs and charges. Proofs are sent directly from the printer to the author. The author should mail correctedproofs to the editorial 1. Moscicki AB, Palefsky JM, Gonzales J, Smith G, Schoolnik GK. Colpo­ office within 48 hours ofreceipt. Failure to meet this deadline may scopic and histologic findings and human papillomavirus (HPV) DNA delay publication. The reprint order form must be returned with test variability in young women positive for HPV DNA. J Infect Dis the corrected proofs even if reprints are not desired. The cost of 1992;166:951-7. excessive changes in proofs will be charged to the author. 2. Mcintosh K. Diagnostic virology. In: Fields BN, Knipe OM, Chanock RM, Nomenclature. It is the intent of the Editor to use the latest et al. Fields virology. 2nd ed. Vol 1. New York: Raven Press, 1990:411­ widely accepted nomenclature. See Approved Lists of Bacterial 40. Names (amended ed., American Society for Microbiology, 1989), 3. Lee LA, PuhrNO, Bean NH, Tauxe RV. Antimicrobial resistance of Salmo­ Bergey's Manual ofDeterminative Bacteriology (9th ed., revised, nel/a isolated from patients in the United States, 1989-1990 [abstract Williams & Wilkins, 1993) and Enzyme Nomenclature 1992: Rec­ 523]. In: Program and abstracts of the 31st Interscience Conference on ommendations ofthe Nomenclature Committee ofthe International Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: Union ofBiochemistry and Molecular Biology on the Nomencla­ American Society for Microbiology, 1991:186. ture and Classification ofEnzymes (Academic Press, 1992). For­ mal terms for virus families, genera, and species should be those Acknowledgment. The page preceding the references can in­ approved by the International Committee on Taxonomy ofViruses: clude a statement thanking those who assisted substantially with Virus Taxonomy-The Classification and Nomenclature of Vi­ work relevant to the study. No acknowledgments are carried with ruses: Sixth Report ofthe International Committee on Taxonomy correspondence. of Viruses (Springer-Verlag, 1995). This volume also includes Statistical analysis. The statistical analyses used should be standard abbreviations for virus species. For names and abbrevia­ identified both in the text and in all tables and figures where the tions of chemical compounds, refer to the Merck Index (1 Ith ed., results of statistical comparison are shown. For guidance on the Merck, 1989). The Editors appreciate the assistance ofauthors and application of statistical methods for analysis ofdata and summa- readers who inform them of changes in nomenclature. Infectious Diseases Society of America

OFFICERS PUBLIC POLICY SUBCOMMITTEE OF PROGRAM PUBLIC RELATIONS DIRECTORS Vincent T. Andriole, President Charles M. Helms (Chair) Stephen H. Zinner (Chair) Donald Armstrong, President-Elect Ruth L. Berkelman John G. Bartlett (Chair) Paul M. Arnow P. Frederick Sparling, Vice-President K. Lynn Cates Martin 1. Blaser Joel Ruskin Catherine M. Wilfert, Secretary- John E. Edwards, Jr. K. Lynn Cates P. Samuel Pegram Treasurer Michael B. Grizzard Theodore C. Eickhoff Ellie 1. C. Goldstein Gerald L. Mandell, Past President Samuel L. Katz STATE AND REGIONAL A. W. Karchmer David E. Rogers SOCIETIES Mark S. Klempner COUNCILLORS William SchatTner Daniel J. Sexton David F. Busch Martin J. Blaser P. Frederick Sparling INTERNATIONAL AFFAIRS Anne A. Gershon TASK FORCE ON HEALTH Stephan E. Lawton, legal counsel Richard L. Guerrant (Chair) David N. Gilbert CARE REFORM Dennis G. Maki H. Erdal Akalin John E. McGowan, Jr. AD HOC COMMITTEES A. Peter Ball Merle A. Sande (Chair) Vincent T. Andriole Walter E. Stamm Claude J. Carbon ACPCOUNCIL Theodore C. Eickhoff Lucy S. Tompkins Roger G. Finch Ronald H. Smith Warren D. Johnson David N. Gilbert Hartmut M. Lode Ellie J. Goldstein STANDING COMMITTEES Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 AIDS S. Ragnar Norrby Peter A. Gross AWARDS Peter D. O'Hanley Charles M. Helms John P. Phair (Chair) Carlos H. Ramirez-Ronda King K. Holmes Robert C. Aber (Chair) Donald Armstrong Daniel Stamboulian Mark S. Klempner Raphael Dolin Judith E. Feinberg J. David Williams Phillip L. Sanchez John N. Sheagren Wayne L. Greaves Jay P. Sanford John E. Bennett Newton E. Hyslop, Jr. LONG-RANGE PLANNING Daniel J. Sexton Robert L. Marier Harold W. Jaffe Thomas G. Slama Henry Masur Gerald L. Mandell (Chair) P. Frederick Sparling CLINICAL AFFAIRS Kenneth H. Mayer Vincent T. Andriole Richard P. Wenzel Thomas C. Quinn Donald Armstrong Thomas G. Slama (Chair) Merle A. Sande P. Frederick Sparling TASK FORCE ON THE VALUE Donald Armstrong Catherine M. Wilfert Merle A. Sande OF THE INFECTIOUS Murray D. Batt R. Gordon Douglas, Jr. Steven 1. Berman DISEASES SPECIALIST Mark J. Kunkel ANTIBIOTIC USE AND CLINICAL TRIALS PHARMACEUTICAL AFFAIRS Richard P. Wenzel (Chair) David B. Martin David C. Classen Daniel J. Sexton William A. Craig (Chair) James E. Pennington (Chair) David S. Fedson Barbara H. Wade Johan S. Bakken Roger W. Baker Richard A. Garibaldi Gregory R. Istre, Pediatric Society Michael Barza Steve Billstein Joseph F. John, Jr. Representative Anthony W. Chow David N. Gilbert Ronald E. Polk Bryan P. Simmons, SHEA liaison George W. Counts David J. Pizzuti Michael Stek, Jr. E. Patchen Dellinger John L. Ryan Robert L. Thompson ETHICS George M. Eliopoulos Francis P. Tally Robert F. Woolson C. Glen Mayhall C. Douglas Webb Paul G. Quie (Chair) Richard D. Meyer TASK FORCE ON WOMEN IN Jack M. Gwaltney, Jr. Robert C. Moellering, Jr. PRACTICE GUIDELINES INFECTIOUS DISEASES Richard B. Hornick S. Ragnar Norrby A. W. Karchmer Alice S. Prince Peter A. Gross (Chair) Lucy S. Tompkins (Chair) Robert L. Marier Fred C. Tenover Murray D. Batt Ward E. Bullock Michael Stek, Jr. (ad hoc) E. Patchen Dellinger Joan L. Drucker FINANCE Linda Ann Sherman (ad hoc) Anne A. Gershon Julie L. Gerberding Peter J. Krause Jerome O. Klein (Chair) Claudio Viscoli (ad hoc) Janet R. Gilsdorf Dennis G. Maki Mary P. Glode Martin J. Blaser William J. Martone Stephan A. Billstein FELLOWSHIP AND YOUNG Mary E. Guinan John E. McGowan,Jr. Philip A. Pizzo Robert Fekety INVESTIGATOR GRANTS Richard L. Sweet Ellie J. C. Goldstein AWARD Richard P. Wenzel TUBERCULOSIS Catherine M. Wilfert, ex officio Ward E. Bullock (Chair) Carol J. Baker PRESIDENT'S ADVISORY Wafaa M. EI-Sadr (Chair) NOMINATIONS Joshua Fierer COMMITTEE David L. Horn Gerald L. Mandell (Chair) Robert T. Schooley Robert C. Horsburgh, Jr. Lucy S. Tompkins Vincent T. Andriole John E. McGowan, Jr. Merle A. Sande Jerome O. Klein R. Gordon Douglas, Jr. Sten H. Vermund Frederick L. Ruben Robert C. Moellering,Jr. Barbara E. Robinson-Dunn Walter J. Hierholzer, Jr. Jack S. Remington Janet R. Gilsdorf INFECTIOUS DISEASES! Gisela F. Schecter INTERNAL MEDICINE Kent A. Sepkowitz PROGRAM Jeffrey R. Starke PUBLICATIONS TRAINING PROGRAM DIRECTORS Jerome O. Klein (Chair) Elias Abrutyn (Chair) Vincent T. Andriole WORKFORCE Anne A. Gershon John G. Bartlett (Chair) Gordon L. Archer Donald Armstrong Theodore C. Eickhoff (Chair) Lucy S. Tompkins Steven 1. Berman John E. McGowan, Jr. Martin 1. Blaser Vincent T. Andriole K. Lynn Cates Martin J. Blaser Charles C. J. Carpenter Carol A. Kauffman Raphael Dolin Walter R. Wilson Henry F. Chambers Elliot Goldstein William E. Dismukes A. W. Karchmer Bruce H. Hamory Philip A. Mackowiak Jack S. Remington Charles V. Sanders, Jr. Keith A. Joiner Elaine C. Jong Merle A. Sande Jay P. Sanford Sydney Finegold, ex officto Mark S. Klempner Robert T. Schooley W. Michael ScheId Steven C. Schoenbaum Marvin Turck, ex officio Richard J. Whitley Catherine M. Wilfert, ex officio Gary K. Schoolnik Ellen R. Wald Catherine M. Wilfert Mark S. Klempner (ex officio) Thomas G. Slama CURRENT CONCEPTS OF CLINICAL INFECTIOUS DISEASE UNIVERSITY OF VIRGINIA APRIL 10-12, 1995 BOAR'SHEAD INN, CHARLOTTESVILLE, VIRGINIA Sponsored by the Office ofContinuing Medical Education, University of Virginia School ofMedicine

GERALD L. MANDELL, M.D., COURSE DIRECTOR JACK M. GWALTNEY, M.D. AND RICHARD L. GUERRANT, M.D., CO-DIRECTORS TOPICS INCLUDE: NEW VACCINES • ANTIMICROBIAL AGENTS • IMMUNOMODULATORS • ENTERIC INFECTIONS TRAVEL MEDICINE • RESPIRATORY INFECTIONS, AIDS, AND NOSOCOMIAL INFECTIONS FACULTY OF THE UNIVERSITY OF VIRGINIA AND GUEST FACULTY INCLUDING: Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 John G. Bartlett, MD. John E. Bennett, MD. Robert C. Moellering, Jr. MD. Division ofInfectious Diseases National Institute ofAllergy Harvard Medical School Johns Hopkins University and Infectious Disease Chairman, Physician-in-Chief School ofMedicine National Institutes ofHealth New Deaconness Hospital

FOR MORE INFORMATION, CONTACT LYNDA MYERS, CME OFFICE (804) 924-5318 -1-800-552-3723 FAX (804) 982-1415 - E-MAIL [email protected]

Post-Doctoral Positions Available Research Opportunities Candida! Genetics and Pathogenesis Developmental Immunology Emerging Infections HIVPathogenesis Molecular Genetics of Antibiotic Resistance Pathogenesis of Persistent Viral Diseases Tick-Borne Infections TumorBiology Molecular Mechanism of TumorInvasion & Metastasis Vaccine Development

DirectApplications to: ------, I I Cancer Biology MicrobialPathogenesis Pediatric InfectiousDiseases PeterP1agemann, Ph.D.s and InfectiousDisease and Developmental Immunology University of Minnesota Ashley Haase, M.D. Margaret K. Hostetter, M.D. Box 196UMHC Box196UMHC Box296 UMHC 420 Delaware St.SE 420 Delaware St. SE 420 Delaware St SE Minneapolis, MN SS4SS Minneapolis, MN SS4SS Minneapolis, MN SS4SS Telephone: 612/624-6190 Telephone: 612/624-6190 Telephone: 612/624-1112 FAX: 6121626-0623 FAX: 6121626-0623 FAX: 612/624-8927

Training program awards areavailable to applicants whoare U.S. citizens or pennanmtresidents. M.D. candidates musthavecompleted a 3-year residency in a medical speciality in an accredited U.S. training program. Applications areeagerly sought fromwomen andminority candidates. The University of Minnesota is anequal opportunity employer. Colorado

Community hospital is recruiting a half to full time infectious disease specialist with strong interest in HIV to join a two­ physician practice. This position offers a competitive compensation package, flexible scheduling, and the opportunity to live near the Rocky Mountains in Boulder, Downloaded from https://academic.oup.com/jid/issue/173/1 by guest on 26 September 2021 Colorado. Competitive salary and bonus.Fax CV to Mike Moran, (303) 440-2435.

Clinical articles in Clinical Infectious Diseases provide you with solid research data and incisive commentaries from leading physicians on the diagnosis and treatment of infectious diseases.Time-saving review ankles in Cl D survey applicable published literature. In addition. frequent supplements focus on recent developments in specific areas of infectious disease research. Published monthly with supplements Editor: Sydney M. Finegold, Staff Physician, lrfe cuous Disease Sec/ion. VAMC. lVe./ Los Angeles, and Professor of Medicine and ofMicrobio logy and Immunology. UCLA School of Medicine Both JID and CID are official publications of the Infectious Diseases Society of America and published by The University of Chicago Press.

REGULAR ONE·YEAR SUBSCRIPTION RATES Comb inationJID/Cl D subscription:$168,60lndividuals; $420.10Institutions; $145.lOASM & IUMSindividual members;S79.IOSpecial (students, interns. residents, fellows: attach copy of valid 10). Outside USA. please add $52 for postage. Canadians, please also add 7% GST. Subscription rates for eitherJID or CID (be sure to indicatewhich journal you arc ordering); S100.OO Individuals; $248.00 Institutions; $87.00 ASM & IUMS individual members; $49.00 Special (students. interns, residents.and fellows; attac h copy of valid IO). Outside USA please add $26 for postage. Canadian s, please also add 7% GST. Airlift delivery service available. Add $70.00 plus postage per journal subscription; $140 per combination lID and CID subscription. (Not available in North America) MasterCard and Visapayments accepted, To order. sendcbeck, purchase order, orcompletecredit card information (acct. #, expodate. phone #, and signature) to The University of Chicago Press, Journals Division, Dept SF6SA, P.O. Box 37005, Chicago, Illinois USA 60637. Credit card customers may fax their order to (312) 753-0811. 10195